{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":60,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":60,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c17a046801e7","filters":{"venue":"Therapeutic Advances in Neurological Disorders"}},"results":[{"id":"W3034546965","doi":"10.1177/1756286420932036","title":"Neurological manifestations and implications of COVID-19 pandemic","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Pandemic; Comorbidity; Neurology; Intensive care medicine; Stroke (engine); Coronavirus; Disease; Hyposmia; Pediatrics; Encephalopathy; Coronavirus disease 2019 (COVID-19); Internal medicine; Psychiatry; Infectious disease (medical specialty)","authors":[{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Valeria Caso","is_ca":false},{"name":"Martin Köhrmann","is_ca":false},{"name":"Carlos A. Molina","is_ca":false},{"name":"Charlotte Cordonnier","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Peter J. Kelly","is_ca":false},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Amanda Chan","is_ca":false},{"name":"Ramin Zand","is_ca":false},{"name":"Amrou Sarraj","is_ca":false},{"name":"Peter D. Schellinger","is_ca":false},{"name":"Konstantinos Voumvourakis","is_ca":false},{"name":"Nikolaos Grigoriadis","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06617230146732682,"gpt":0.4122730557635806,"spread":0.3461007542962538,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006517212,0.0003418062,0.0004554368,0.001449357,0.000299869,0.001079962,0.0003716754,0.0007711007,0.001839895],"category_scores_gemma":[0.003343781,0.0001189399,0.0005508743,0.001049126,0.0005271439,0.00107056,0.0005524808,0.0007644205,0.0002559928],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008561829,"about_ca_system_score_gemma":0.001901474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003592496,"about_ca_topic_score_gemma":0.005209427,"domain_scores_codex":[0.9994249,0.0002003133,0.0001500729,0.00006419913,0.0001139919,0.00004647304],"domain_scores_gemma":[0.9989405,0.0003987202,0.0003612239,0.00002110247,0.0002318149,0.00004661489],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004527905,0.00004979872,0.01920966,0.08020027,0.001109388,0.02146134,0.002699028,0.000983806,0.002874597,0.01002202,0.1206912,0.7402461],"study_design_scores_gemma":[0.00006295623,0.0003142724,0.05094575,0.07774428,0.00142572,0.08897346,0.003336864,0.0003997606,0.001332893,0.008714136,0.7665973,0.0001526919],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005189655,0.9853639,0.0001841148,0.00481344,0.000800096,0.00001925022,0.0001575035,0.0000119567,0.003459968],"genre_scores_gemma":[0.04301445,0.9506893,0.0003250519,0.003274808,0.001652776,0.00002372169,0.0001973977,0.000004747837,0.0008177788],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003592496,"threshold_uncertainty_score":0.00714314,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3111513828","doi":"10.1177/1756286420978004","title":"COVID-19 and cerebrovascular diseases: a comprehensive overview","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Stroke (engine); Intracerebral hemorrhage; Disease; Intensive care medicine; Coagulopathy; Internal medicine; Subarachnoid hemorrhage","authors":[{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Ramin Zand","is_ca":false},{"name":"Vasileios Lioutas","is_ca":false},{"name":"Christos Krogias","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Ashkan Shoamanesh","is_ca":true},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Shima Shahjouei","is_ca":false},{"name":"Claudio Baracchini","is_ca":false},{"name":"Charalambos Vlachopoulos","is_ca":false},{"name":"Rossetos Gournellis","is_ca":false},{"name":"Petros P. Sfikakis","is_ca":false},{"name":"Else Charlotte Sandset","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05047681182604093,"gpt":0.3874367768063144,"spread":0.3369599649802735,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009316187,0.0006572652,0.001236603,0.005241981,0.0003264283,0.001321723,0.0006129686,0.001007945,0.002552123],"category_scores_gemma":[0.002372221,0.0003252138,0.001242014,0.003978108,0.0003665366,0.00141474,0.000819968,0.0009551684,0.0003569853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007527748,"about_ca_system_score_gemma":0.002810356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002862633,"about_ca_topic_score_gemma":0.004303213,"domain_scores_codex":[0.999566,0.00009513731,0.0001572694,0.0000703334,0.00007673313,0.00003449232],"domain_scores_gemma":[0.9980547,0.001290574,0.0003506352,0.00003010085,0.0002039457,0.00007002369],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003106528,0.00009207794,0.004025453,0.2590833,0.001502829,0.0008574828,0.0005545512,0.0004243253,0.001011929,0.003636953,0.0293924,0.6991081],"study_design_scores_gemma":[0.00005198073,0.0004058199,0.01956676,0.2283845,0.005198177,0.007485639,0.0006521614,0.0002863925,0.0003819925,0.003480538,0.7340183,0.00008768826],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000217602,0.9991443,0.00003550517,0.0002674736,0.00007787259,0.000005289839,0.00003235892,0.000002410264,0.0002172188],"genre_scores_gemma":[0.001605851,0.997709,0.0001358841,0.0002286058,0.0001792695,0.00001018435,0.00005546703,8.309333e-7,0.00007485961],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005241981,"threshold_uncertainty_score":0.00853771,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2103958324","doi":"10.1177/1756285611406166","title":"Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Circadian rhythm and melatonin","field":"Neuroscience","cited_by":112,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Brock University; University of Toronto; Centre for Addiction and Mental Health","funders":"Universidad de Buenos Aires; Consejo Nacional de Investigaciones Científicas y Técnicas","keywords":"Melatonin; Neuroprotection; Parkinson's disease; Medicine; Substantia nigra; Agomelatine; Circadian rhythm; Disease; Neuroscience; Melatonin receptor; REM sleep behavior disorder; Sleep (system call); Pharmacology; Internal medicine; Psychology; Hippocampus; Antidepressant","authors":[{"name":"Venkatramanujam Srinivasan","is_ca":false},{"name":"Daniel P. Cardinali","is_ca":false},{"name":"U Srinivasan","is_ca":false},{"name":"Charanjit Kaur","is_ca":false},{"name":"Gregory M. Brown","is_ca":true},{"name":"D. Warren Spence","is_ca":true},{"name":"Rüdiger Hardeland","is_ca":false},{"name":"Seithikurippu R. Pandi‐Perumal","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0242184085777944,"gpt":0.252517391484598,"spread":0.2282989829068036,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002359139,0.0002991908,0.000429133,0.0003653061,0.0001537256,0.0002478794,0.0002746062,0.0005644167,0.001567834],"category_scores_gemma":[0.0001139285,0.00006298211,0.0002793886,0.0002352686,0.0001988842,0.0003447799,0.0001804339,0.000616588,0.0002444056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001731283,"about_ca_system_score_gemma":0.0001538197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002230197,"about_ca_topic_score_gemma":0.0007517937,"domain_scores_codex":[0.9999644,0.00001320194,0.000002967275,0.000006428235,0.000005988501,0.000007068881],"domain_scores_gemma":[0.9999657,0.00001053428,0.00000926879,0.000002249903,0.000004950157,0.000007225531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003530833,0.00097185,0.000759654,0.002968935,0.0001257073,0.001069439,0.0001477727,0.0006747629,0.2392761,0.006544017,0.003738303,0.7401927],"study_design_scores_gemma":[0.00281839,0.05876403,0.02254321,0.001347103,0.0008061242,0.009220101,0.0004024235,0.003024116,0.238665,0.01323235,0.649054,0.0001231671],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.08669518,0.9005876,0.002214832,0.00245499,0.0004930625,0.00006130682,0.00007201154,0.0000755752,0.007345462],"genre_scores_gemma":[0.4040807,0.5837292,0.004047891,0.001130442,0.001026859,0.00008704508,0.0001318057,0.00001966965,0.005746329],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.001567834,"threshold_uncertainty_score":0.00524497,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085475081","doi":"10.1177/1756285609102724","title":"Review: Therapy for Alzheimer's disease: how effective are current treatments?","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":105,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Memantine; Medicine; Tolerability; Disease; Rivastigmine; Alzheimer's disease; Cholinesterase; Neurotransmitter receptor; Intensive care medicine; Pharmacology; Donepezil; Internal medicine; Dementia; Receptor; Adverse effect","authors":[{"name":"Krista L. Lanctôt","is_ca":true},{"name":"Ryan D. Rajaram","is_ca":true},{"name":"Nathan Herrmann","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03884627347654957,"gpt":0.3714684075139778,"spread":0.3326221340374282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00207456,0.001306683,0.006086178,0.002325607,0.00046047,0.001791533,0.001462996,0.003103371,0.006632613],"category_scores_gemma":[0.009975703,0.0003484988,0.001666213,0.004063446,0.000794194,0.002167893,0.0005120853,0.001653955,0.001576671],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001464277,"about_ca_system_score_gemma":0.002601965,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003511524,"about_ca_topic_score_gemma":0.008317316,"domain_scores_codex":[0.9988142,0.0005470401,0.0002336581,0.00008881874,0.0002776768,0.00003863159],"domain_scores_gemma":[0.9967169,0.002172137,0.0004691293,0.00004278249,0.0004789396,0.000120086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0007312793,0.00004585945,0.0003527369,0.3144816,0.002665188,0.0002474672,0.0001016015,0.0003888484,0.0003365861,0.001437323,0.1375601,0.5416515],"study_design_scores_gemma":[0.0007923151,0.0004026664,0.004824827,0.3710738,0.01551727,0.001370542,0.0004391794,0.0002958799,0.000345301,0.00544594,0.5994148,0.00007739172],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005969391,0.9977354,0.0000443547,0.001299307,0.0005358015,0.00001624229,0.00003717513,0.000003938724,0.000268118],"genre_scores_gemma":[0.001221213,0.9964557,0.0001455345,0.001467115,0.0004470943,0.00002582518,0.00003093338,0.000001781543,0.0002048714],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006632613,"threshold_uncertainty_score":0.02218837,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3025164808","doi":"10.1177/1756286420915005","title":"Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years’ follow-up of DEFINE, CONFIRM, and ENDORSE","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Dimethyl fumarate; Medicine; Multiple sclerosis; Adverse effect; Expanded Disability Status Scale; Cohort; Placebo; Incidence (geometry); Internal medicine; Population; Relapsing remitting; Magnetic resonance imaging; Gastroenterology; Pathology; Radiology; Immunology","authors":[{"name":"Ralf Gold","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Amit Bar‐Or","is_ca":false},{"name":"Robert J. Fox","is_ca":false},{"name":"Ludwig Kappos","is_ca":false},{"name":"Chongshu Chen","is_ca":false},{"name":"Becky Parks","is_ca":false},{"name":"Catherine Miller","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03160701660016953,"gpt":0.272147108999602,"spread":0.2405400923994324,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003050132,0.000496219,0.001286541,0.0004091265,0.0005877981,0.0006674296,0.0003440282,0.0004977309,0.0009893497],"category_scores_gemma":[0.002201094,0.0002491959,0.0008907379,0.0003449466,0.0002679244,0.0007085446,0.000420122,0.000889888,0.0003994969],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004032858,"about_ca_system_score_gemma":0.0002720514,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005963924,"about_ca_topic_score_gemma":0.001126088,"domain_scores_codex":[0.9991679,0.0002333508,0.0001128026,0.0001405608,0.0002252462,0.0001201412],"domain_scores_gemma":[0.9969805,0.0004206942,0.001414366,0.0003339407,0.0004403677,0.0004102449],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04695043,0.002148233,0.8626403,0.0003460713,0.001495421,0.0004862902,0.0005474157,0.0004485584,0.01059724,0.00005242416,0.001507915,0.07277977],"study_design_scores_gemma":[0.001901088,0.02255347,0.9689403,0.0000350004,0.0006403689,0.0008043002,0.0001079748,0.0003943979,0.002354101,0.0000462616,0.002187783,0.00003503537],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972996,0.0008783226,0.0001970836,0.00007105253,0.0000134095,0.0000889205,0.0007273573,0.00002884377,0.0006953513],"genre_scores_gemma":[0.9977261,0.0002009798,0.0002137901,0.0001025337,0.00002401586,0.00006126667,0.001289729,0.000004639669,0.0003769427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003050132,"threshold_uncertainty_score":0.01613086,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2167117206","doi":"10.1177/1756285614546855","title":"Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Fungal Plant Pathogen Control","field":"Agricultural and Biological Sciences","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Teriflunomide; Medicine; Multiple sclerosis; Tolerability; Context (archaeology); Clinical trial; Intensive care medicine; Relapsing remitting; Alternative medicine; Investigational Drugs; Adverse effect; Pharmacology; Internal medicine; Fingolimod; Immunology; Pathology","authors":[{"name":"Jiwon Oh","is_ca":true},{"name":"Paul O’Connor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06633268888999329,"gpt":0.2972254118672915,"spread":0.2308927229772982,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005961935,0.000593386,0.001187491,0.001911989,0.0002342897,0.0008900915,0.0006614418,0.0008801016,0.003611184],"category_scores_gemma":[0.0006487018,0.000182561,0.0004602644,0.002067514,0.0003608997,0.001061439,0.0005333336,0.001323948,0.001362517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003468,"about_ca_system_score_gemma":0.0008689538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007497843,"about_ca_topic_score_gemma":0.001503735,"domain_scores_codex":[0.9998465,0.00002857911,0.00003189447,0.00002640095,0.00005217457,0.00001437589],"domain_scores_gemma":[0.9996959,0.0001611361,0.00005297579,0.000006645575,0.00005880888,0.00002452847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001245707,0.0000794235,0.0001620513,0.02384225,0.0001059506,0.0002021247,0.00005933996,0.0002069061,0.001736683,0.001727567,0.01103537,0.9607177],"study_design_scores_gemma":[0.00005213508,0.0002295068,0.001432378,0.01039861,0.0004183931,0.002026364,0.000141382,0.00012457,0.0007994244,0.002341187,0.9820105,0.00002544746],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009245794,0.999341,0.00004384527,0.0001255468,0.0000610802,0.000002244529,0.00000838388,0.000002771344,0.0003227016],"genre_scores_gemma":[0.0004653627,0.999158,0.0001016952,0.00007634465,0.00006422117,0.000002678691,0.000009663518,5.152605e-7,0.0001215369],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003611184,"threshold_uncertainty_score":0.01208061,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163670346","doi":"10.1177/1756285610391693","title":"Impact of exposure to interferon beta-1a on outcomes in patients with relapsing–remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Multiple sclerosis; Expanded Disability Status Scale; Internal medicine; Interferon beta-1a; Placebo; Randomized controlled trial; Gastroenterology; Quartile; Confidence interval; Interferon beta; Immunology; Pathology","authors":[{"name":"Bernard M.J. Uitdehaag","is_ca":false},{"name":"Cris S. Constantinescu","is_ca":false},{"name":"Peter Cornelisse","is_ca":false},{"name":"Douglas Jeffery","is_ca":false},{"name":"Ludwig Kappos","is_ca":false},{"name":"David Li","is_ca":true},{"name":"Magnhild Sandberg‐Wollheim","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"E. Verdun","is_ca":false},{"name":"Víctor M. Rivera","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1420817650018123,"gpt":0.3665192244154442,"spread":0.2244374594136319,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007900273,0.0005818058,0.001254188,0.0004858203,0.0003100327,0.0007499044,0.0006442856,0.0006685042,0.00151186],"category_scores_gemma":[0.008503311,0.000251529,0.002868311,0.0006084469,0.000431829,0.0007101277,0.0009002635,0.001322669,0.0001426365],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003085545,"about_ca_system_score_gemma":0.0004099094,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005971763,"about_ca_topic_score_gemma":0.0006540081,"domain_scores_codex":[0.9938031,0.004163268,0.0003816473,0.0006003266,0.0007177781,0.0003338222],"domain_scores_gemma":[0.988099,0.005763362,0.003828518,0.000972056,0.0004663433,0.0008706792],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1080761,0.001067372,0.8669284,0.0002886948,0.01037991,0.0002381468,0.0002031239,0.0007726651,0.001292818,0.00005222443,0.0002767031,0.01042405],"study_design_scores_gemma":[0.00135989,0.01114178,0.9842386,0.00002085834,0.001868557,0.0001245017,0.00009320625,0.0005987317,0.0002410335,0.00006320469,0.0002312062,0.0000185287],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984235,0.0007703428,0.0001432333,0.00004386952,0.000008210256,0.00002748803,0.0003609383,0.000004575539,0.0002179118],"genre_scores_gemma":[0.999207,0.00008622404,0.00008858562,0.00003252986,0.00002038731,0.00003655269,0.0004432328,0.000002400056,0.00008310508],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007900273,"threshold_uncertainty_score":0.04178113,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2944153925","doi":"10.1177/1756286419843458","title":"Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson’s disease: A pilot study","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Mirabegron; Overactive bladder; Urinary incontinence; Quality of life (healthcare); Urinary urgency; Parkinson's disease; Visual analogue scale; Refractory (planetary science); Montreal Cognitive Assessment; Urinary system; Rating scale; Urology; Physical therapy; Internal medicine; Disease; Cognitive impairment","authors":[{"name":"Marilena Gubbiotti","is_ca":false},{"name":"Antonella Conte","is_ca":false},{"name":"Savino M. Di Stasi","is_ca":false},{"name":"Nicola Tambasco","is_ca":false},{"name":"Antonella Giannantoni","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03204323492826271,"gpt":0.3429366496495084,"spread":0.3108934147212457,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001193287,0.0003965073,0.0009599156,0.00020832,0.0003360283,0.0003721973,0.0002342946,0.0004535978,0.001585673],"category_scores_gemma":[0.001352582,0.0001797877,0.0007640161,0.0001877396,0.0004243082,0.0003845462,0.0002749187,0.0005198283,0.0003017701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000222877,"about_ca_system_score_gemma":0.0005402811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003767404,"about_ca_topic_score_gemma":0.0004615986,"domain_scores_codex":[0.9996701,0.0001776118,0.00002822803,0.00004155791,0.00004240214,0.00004002084],"domain_scores_gemma":[0.9992448,0.0002718758,0.0001260303,0.00005871993,0.00006335119,0.0002352321],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.423715,0.08329853,0.136665,0.001335368,0.000936774,0.003332186,0.001391744,0.001207638,0.09169996,0.0001676117,0.0007652591,0.2554849],"study_design_scores_gemma":[0.03236375,0.8474004,0.1120974,0.00003958646,0.0004172382,0.001447986,0.0002045678,0.0008604613,0.003412031,0.00004265859,0.001685008,0.00002895572],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988185,0.0006329587,0.00009054656,0.00004120966,0.00001029881,0.0001373358,0.0000381303,0.000004329216,0.0002266475],"genre_scores_gemma":[0.9983758,0.0004978881,0.0004751131,0.000100814,0.00006213574,0.0001744158,0.0001585353,0.00000224509,0.0001529991],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001585673,"threshold_uncertainty_score":0.006310761,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3157239883","doi":"10.1177/1756286420982134","title":"Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"NIHR Cambridge Biomedical Research Centre; Bayer HealthCare; National Institute for Health and Care Research; Sanofi","keywords":"Alemtuzumab; Medicine; Multiple sclerosis; Internal medicine; Clinical trial; Randomized controlled trial; Immunology; Transplantation","authors":[{"name":"Alasdair Coles","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Ann Bass","is_ca":false},{"name":"Aaron Boster","is_ca":false},{"name":"D. A. S. Compston","is_ca":false},{"name":"Óscar Fernández","is_ca":false},{"name":"Eva Havrdová","is_ca":false},{"name":"Kunio Nakamura","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"Tjalf Ziemssen","is_ca":false},{"name":"David Margolin","is_ca":false},{"name":"Xiaobi Huang","is_ca":false},{"name":"Nadia Daizadeh","is_ca":false},{"name":"Madalina Chirieac","is_ca":false},{"name":"Krzysztof Selmaj","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04590724287686678,"gpt":0.3464066050044256,"spread":0.3004993621275588,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006598852,0.001211486,0.002198344,0.0003359053,0.0006507352,0.001166197,0.0008311789,0.001811498,0.001743165],"category_scores_gemma":[0.00536595,0.0003279258,0.001895969,0.0004809549,0.0007035972,0.0009421387,0.0006666696,0.002290191,0.0003944167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009024067,"about_ca_system_score_gemma":0.001195966,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001119393,"about_ca_topic_score_gemma":0.001632066,"domain_scores_codex":[0.9979209,0.00120827,0.0001063357,0.0002621154,0.0002252818,0.0002770662],"domain_scores_gemma":[0.9966257,0.000536254,0.001071406,0.0004136614,0.0004607066,0.0008923556],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9117939,0.005355331,0.0218057,0.0003703271,0.004001849,0.0001826652,0.0001574998,0.001804907,0.004259757,0.0002182344,0.00665502,0.04339484],"study_design_scores_gemma":[0.6955218,0.15668,0.1256118,0.0001933024,0.006865869,0.0005387468,0.00008176769,0.002168275,0.002666784,0.0007026503,0.00886394,0.0001049977],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867471,0.007840643,0.0003317614,0.0006925019,0.0001529817,0.0005665109,0.001708211,0.00005478185,0.001905457],"genre_scores_gemma":[0.9878353,0.001916819,0.001021178,0.001065326,0.0004414263,0.00100036,0.004736755,0.00002143104,0.00196129],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006598852,"threshold_uncertainty_score":0.03489846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131043834","doi":"10.1177/1756285613476127","title":"Diagnosis and treatment of impulse control disorders in patients with movement disorders","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Impulse control; Medicine; Movement disorders; Impulsivity; Psychiatry; Parkinson's disease; Amantadine; Parkinsonism; Impulse control disorder; Antipsychotic; Disease; Internal medicine; Pathological; Schizophrenia (object-oriented programming)","authors":[{"name":"Tiago Mestre","is_ca":true},{"name":"Antonio P. Strafella","is_ca":true},{"name":"Teri Thomsen","is_ca":false},{"name":"Valerie Voon","is_ca":false},{"name":"Janis M. Miyasaki","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007107237729423374,"gpt":0.2430266283361677,"spread":0.2359193906067444,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003389172,0.0001475157,0.0004531496,0.0004684716,0.000448484,0.0003352955,0.0002151789,0.0005553124,0.001867286],"category_scores_gemma":[0.001502519,0.00008665751,0.0003677213,0.0003756962,0.0001459498,0.0002598406,0.0002513777,0.0006272006,0.0003820311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004292719,"about_ca_system_score_gemma":0.0007216267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001351714,"about_ca_topic_score_gemma":0.003011408,"domain_scores_codex":[0.9997273,0.00009865752,0.00005203837,0.00002458348,0.00005684063,0.00004046218],"domain_scores_gemma":[0.9996768,0.00007642378,0.00009757827,0.00001085448,0.00004371289,0.00009455221],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001919741,0.003026369,0.2737353,0.001172998,0.0001693498,0.006546428,0.0005435591,0.0002846066,0.002518854,0.000904678,0.0138442,0.695334],"study_design_scores_gemma":[0.001480902,0.006386878,0.9017432,0.00188529,0.0004027704,0.02926975,0.001071879,0.0009914057,0.001827902,0.002064936,0.0528115,0.0000635574],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7265065,0.1808625,0.002899454,0.01798275,0.00096363,0.0007799889,0.0006825475,0.0002121518,0.0691103],"genre_scores_gemma":[0.9451862,0.04019095,0.004328978,0.003702109,0.001043968,0.0003140765,0.0006518762,0.00001260848,0.004569176],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.001867286,"threshold_uncertainty_score":0.006246746,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2899137047","doi":"10.1177/1756286418804760","title":"Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Sphingolipid Metabolism and Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Novartis Pharma; IC Design Education Center; Biogen; Ipsen; Novartis","keywords":"Fingolimod; Medicine; Multiple sclerosis; Pregnancy; Natalizumab; Intensive care medicine; Internal medicine; Immunology","authors":[{"name":"Yvonne Geissbühler","is_ca":false},{"name":"Jere Vile","is_ca":false},{"name":"Gideon Koren","is_ca":true},{"name":"Morgane Guennec","is_ca":false},{"name":"Helmut Butzkueven","is_ca":false},{"name":"Hugh H. Tilson","is_ca":false},{"name":"Thomas M. MacDonald","is_ca":false},{"name":"Kerstin Hellwig","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01914898633168949,"gpt":0.26108031739118,"spread":0.2419313310594906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002190482,0.0002508216,0.0004085758,0.001449312,0.0003868295,0.0006485932,0.0003148324,0.0003825035,0.0009700324],"category_scores_gemma":[0.007474982,0.0001714007,0.0004749163,0.001036807,0.000342368,0.0004508385,0.0005724781,0.0005892911,0.0001680354],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005327414,"about_ca_system_score_gemma":0.000659504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001478192,"about_ca_topic_score_gemma":0.00105362,"domain_scores_codex":[0.9989592,0.0004748409,0.0001570792,0.0001401512,0.000156012,0.0001127338],"domain_scores_gemma":[0.9957558,0.001362809,0.002128467,0.0001467812,0.0002774058,0.000328754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004048904,0.00002849961,0.9945636,0.00002786066,0.00003116351,0.0002489316,0.00009463502,0.00006693721,0.0001207567,0.00002789573,0.00004954911,0.004335352],"study_design_scores_gemma":[0.00002069376,0.000892938,0.9936278,0.00005698191,0.0001160997,0.003093302,0.000310795,0.0005684353,0.0005811804,0.0001260064,0.0005932746,0.00001255401],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954852,0.00171257,0.0004400042,0.0001183555,0.000008776194,0.0000591757,0.0007138619,0.00001117373,0.001450937],"genre_scores_gemma":[0.9978372,0.0007596355,0.0005241647,0.00004456173,0.00001377578,0.00006835272,0.0005452938,0.000002970044,0.0002040409],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002190482,"threshold_uncertainty_score":0.01158452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3037795043","doi":"10.1177/1756286420935019","title":"Expert opinion on the use of cladribine tablets in clinical practice","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Expert opinion; Cladribine; Clinical Practice; Alternative medicine; Intensive care medicine; Traditional medicine; Medical physics; Family medicine; Internal medicine; Pathology","authors":[{"name":"Per Soelberg Sørensen","is_ca":false},{"name":"Diego Centonze","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Xavier Montalbán","is_ca":true},{"name":"Daniel Selchen","is_ca":true},{"name":"Patrick Vermersch","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Bassem Yamout","is_ca":false},{"name":"Hashem Salloukh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3616787011441253,"gpt":0.5036940022402069,"spread":0.1420153010960816,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02435427,0.0008821028,0.002420771,0.002628364,0.0004142565,0.002158027,0.002889677,0.004481678,0.005446887],"category_scores_gemma":[0.05793379,0.0005045446,0.001747948,0.002772841,0.0009805612,0.002268617,0.001549395,0.002649585,0.001885226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002357847,"about_ca_system_score_gemma":0.008742293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002602621,"about_ca_topic_score_gemma":0.003737099,"domain_scores_codex":[0.9771215,0.01132186,0.005601943,0.0008867009,0.004587583,0.0004803722],"domain_scores_gemma":[0.9402494,0.03810137,0.006441131,0.0007922424,0.01347409,0.0009417376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001824187,0.00004181696,0.0003939135,0.196892,0.000569707,0.0003025338,0.0005597014,0.0002986242,0.0006492,0.002984169,0.1079258,0.6892],"study_design_scores_gemma":[0.0001546654,0.0001184577,0.001534778,0.2956626,0.001455392,0.0006411358,0.0004627219,0.0002033541,0.0004233162,0.002958858,0.6963345,0.00005016455],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000374287,0.9653949,0.0009847317,0.02358214,0.004202906,0.0001994513,0.0002172248,0.00002012319,0.005024196],"genre_scores_gemma":[0.008085676,0.9746963,0.003927115,0.009797399,0.001660826,0.0002934244,0.0003184293,0.000009592641,0.001211219],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02435427,"threshold_uncertainty_score":0.1287992,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3125508314","doi":"10.1177/1756286420986727","title":"Real-world comparative safety and efficacy of tenecteplase <i>versus</i> alteplase in acute ischemic stroke patients with large vessel occlusion","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Tenecteplase; Medicine; Thrombolysis; Modified Rankin Scale; Stroke (engine); Fibrinolytic agent; Occlusion; Tissue plasminogen activator; Internal medicine; Anesthesia; Ischemia; Ischemic stroke; Myocardial infarction","authors":[{"name":"Klearchos Psychogios","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Georgios Magoufis","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Ermioni Papageorgiou","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Konstantinos Voumvourakis","is_ca":false},{"name":"Elias Broutzos","is_ca":false},{"name":"Elefterios Stamboulis","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01186310991751156,"gpt":0.2901336311178049,"spread":0.2782705212002933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001925686,0.0002134512,0.0004310515,0.0002416499,0.0002017994,0.0005438511,0.0001815112,0.0003458788,0.000945984],"category_scores_gemma":[0.004229832,0.0001027394,0.0004156263,0.0002401549,0.0004561711,0.0004220268,0.0002060785,0.0003601857,0.0001966865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004814459,"about_ca_system_score_gemma":0.0002862454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004133462,"about_ca_topic_score_gemma":0.0004114567,"domain_scores_codex":[0.9987447,0.0007219845,0.0001498241,0.0001945772,0.0001068633,0.00008202148],"domain_scores_gemma":[0.9952374,0.00169891,0.002056962,0.0002499155,0.0002859639,0.000470834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.346964,0.007563904,0.5675204,0.0004712253,0.001852466,0.0005533451,0.0004941536,0.00165214,0.009646452,0.0001667421,0.0007729948,0.06234211],"study_design_scores_gemma":[0.01605382,0.1758105,0.7980743,0.00005308026,0.001140203,0.001036912,0.0002407708,0.002508824,0.003891204,0.0001340261,0.0009931242,0.0000630959],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995502,0.0001269047,0.00005123546,0.00001145322,0.000003476646,0.00002652482,0.0000673812,0.000002292675,0.0001606399],"genre_scores_gemma":[0.9996284,0.00005402071,0.00007442448,0.00002237518,0.00001570381,0.00002428059,0.0001566469,8.30615e-7,0.00002322538],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001925686,"threshold_uncertainty_score":0.01018417,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3164111830","doi":"10.1177/17562864211018561","title":"Cannabis and its derivatives for the use of motor symptoms in Parkinson’s disease: a systematic review and meta-analysis","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Meta-analysis; Parkinson's disease; Motor symptoms; Disease; Cannabis; Systematic review; Psychiatry; Neuroscience; MEDLINE; Physical medicine and rehabilitation; Intensive care medicine; Internal medicine; Psychology","authors":[{"name":"Susan J. Thanabalasingam","is_ca":true},{"name":"Brandan Ranjith","is_ca":true},{"name":"Robyn Jackson","is_ca":true},{"name":"Don Thiwanka Wijeratne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1150643569412122,"gpt":0.3927733063084333,"spread":0.2777089493672211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009451416,0.002412494,0.01589723,0.006504581,0.0007052597,0.002708441,0.001973262,0.001937035,0.003712629],"category_scores_gemma":[0.02416781,0.001156937,0.03276951,0.006675008,0.0006515076,0.001414642,0.001347472,0.001373991,0.0002496956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002396262,"about_ca_system_score_gemma":0.003919929,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006390386,"about_ca_topic_score_gemma":0.01407572,"domain_scores_codex":[0.9930801,0.002977476,0.002131878,0.000701134,0.000858368,0.0002509868],"domain_scores_gemma":[0.9828854,0.0121605,0.002981937,0.0004684354,0.001251571,0.0002521882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002157278,0.00004235754,0.00450823,0.4636964,0.5143263,0.0001583686,0.00007585056,0.0004634631,0.0002542037,0.0001123612,0.0006264736,0.01357866],"study_design_scores_gemma":[0.0005677723,0.0002166563,0.004256936,0.03065544,0.9623128,0.0001347481,0.00004694313,0.0001829602,0.0001083937,0.0001402875,0.001352993,0.00002405525],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004860865,0.9938632,0.0002731027,0.0001348255,0.00008589101,0.0002149268,0.0003794847,0.00001577073,0.0001719075],"genre_scores_gemma":[0.1429344,0.8527236,0.00159188,0.0005875835,0.0002308247,0.0009091207,0.0007463051,0.00002049771,0.0002558608],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01589723,"threshold_uncertainty_score":0.04998446,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2405578566","doi":"10.1177/1756285616648060","title":"Quantitative analysis of multiple sclerosis patients’ preferences for drug treatment: a best–worst scaling study","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre for Advancing Health Outcomes; University of Saskatchewan; Sunnybrook Hospital; Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Multiple sclerosis; Drug; Preference; Latent class model; Logistic regression; Pharmacotherapy; Intensive care medicine; Internal medicine; Pharmacology; Psychiatry; Machine learning; Statistics","authors":[{"name":"Larry D. Lynd","is_ca":true},{"name":"Anthony Traboulsee","is_ca":true},{"name":"Carlo A. Marra","is_ca":true},{"name":"Nicole Mittmann","is_ca":true},{"name":"Charity Evans","is_ca":true},{"name":"Kathy H. Li","is_ca":true},{"name":"Melanie Carter","is_ca":true},{"name":"Celestin Hategekimana","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1248552293789991,"gpt":0.373623922066754,"spread":0.2487686926877549,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007690741,0.0002403959,0.0004246947,0.0007905049,0.0008473344,0.001117414,0.0003162152,0.0002930737,0.00238698],"category_scores_gemma":[0.02294967,0.0001219919,0.0009921886,0.001065096,0.001117242,0.0006544184,0.000753584,0.0005613319,0.0001105833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002630188,"about_ca_system_score_gemma":0.001434376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02194152,"about_ca_topic_score_gemma":0.02719006,"domain_scores_codex":[0.9953817,0.002821693,0.000353892,0.000273142,0.0009102658,0.0002594584],"domain_scores_gemma":[0.9807566,0.01133985,0.0040378,0.0008630611,0.002075805,0.0009268982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001388174,0.0004317632,0.9475869,0.0001667718,0.0005227926,0.0001302467,0.01354962,0.001430005,0.001159369,0.0008611422,0.0007316777,0.03204163],"study_design_scores_gemma":[0.000124667,0.001013946,0.9640839,0.00007566198,0.0001490421,0.0002204883,0.02397192,0.006911744,0.0005178723,0.001250628,0.001604608,0.0000755106],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985467,0.00004712223,0.0005194369,0.00006877849,0.000001988099,0.00005419376,0.0001287229,0.000001771703,0.000631226],"genre_scores_gemma":[0.9993513,0.00001931705,0.0004256806,0.00001735514,0.000001557785,0.00003631552,0.00008096605,8.270425e-7,0.00006661026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02194152,"threshold_uncertainty_score":0.04362762,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4405574148","doi":"10.1177/17562864241306684","title":"Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Multiple sclerosis; Medicine; Pathology; Neuroinflammation; Disease; Biomarker; Neuroscience; Bioinformatics; Immunology; Biology","authors":[{"name":"Assunta Dal‐Bianco","is_ca":false},{"name":"Jiwon Oh","is_ca":true},{"name":"Pascal Sati","is_ca":false},{"name":"Martina Absinta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2637609567356469,"gpt":0.4525095405371548,"spread":0.1887485838015078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002534522,0.0009802614,0.001557001,0.006032118,0.0006321628,0.001834303,0.00134095,0.001036595,0.001760506],"category_scores_gemma":[0.003708699,0.0002035261,0.0006123651,0.005912338,0.002070937,0.001970247,0.001418789,0.001813922,0.001712698],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00122772,"about_ca_system_score_gemma":0.002358661,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0023533,"about_ca_topic_score_gemma":0.003177657,"domain_scores_codex":[0.9983582,0.0004509102,0.0004546182,0.0002131917,0.0004027433,0.0001202943],"domain_scores_gemma":[0.9979342,0.0005523016,0.0006461788,0.00006124369,0.0006000603,0.0002059979],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005743341,0.000138339,0.01951333,0.0125302,0.0002321037,0.0009533549,0.001449102,0.0004317061,0.006088651,0.01441453,0.0880906,0.8555837],"study_design_scores_gemma":[0.00009996623,0.0007111083,0.06484082,0.01349221,0.0004160766,0.02227706,0.00152649,0.0007530021,0.001040058,0.02394354,0.8707179,0.0001816692],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009227908,0.9734292,0.004285002,0.004592936,0.002664177,0.0002342357,0.0007591892,0.00009863764,0.004708677],"genre_scores_gemma":[0.05193587,0.9036438,0.02375988,0.004819883,0.008017682,0.0004928761,0.003690289,0.0001109137,0.003528798],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006032118,"threshold_uncertainty_score":0.01340401,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1969905648","doi":"10.1177/1756285609336548","title":"Implementation of computer-based language therapy in aphasia","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurobiology of Language and Bilingualism","field":"Neuroscience","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"Canadian Stroke Network","keywords":"Aphasia; Medicine; Intervention (counseling); Comprehension; Speech therapy; Audiology; Psychiatry; Linguistics","authors":[{"name":"Lisa M. D. Archibald","is_ca":true},{"name":"J. B. Orange","is_ca":false},{"name":"Donald J. Jamieson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02229337063971252,"gpt":0.3492101549210659,"spread":0.3269167842813534,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008371319,0.0003297834,0.0003392559,0.0004613311,0.0006038958,0.0003556637,0.0004049134,0.0004067532,0.001612699],"category_scores_gemma":[0.003477079,0.00009416744,0.0002200228,0.0002854545,0.0004260161,0.0003525537,0.0007847,0.0004076918,0.0002208153],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006499314,"about_ca_system_score_gemma":0.001775362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003590848,"about_ca_topic_score_gemma":0.007391233,"domain_scores_codex":[0.9993476,0.0002674805,0.00006563025,0.0001019664,0.00009611281,0.0001211924],"domain_scores_gemma":[0.9990727,0.0002932262,0.00008944864,0.0001286458,0.0001389893,0.0002770425],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004084432,0.04308816,0.04733542,0.0005397086,0.0001441349,0.0009596201,0.007216606,0.002479456,0.03329202,0.0004097825,0.0008335106,0.8596171],"study_design_scores_gemma":[0.00590756,0.2200404,0.7145845,0.0003232925,0.0005079762,0.003407101,0.005175223,0.005999538,0.02690419,0.00152438,0.01550872,0.0001170565],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974447,0.0001049993,0.0006870839,0.00006216548,0.000007619306,0.0005037971,0.00002084448,0.00003577538,0.001132905],"genre_scores_gemma":[0.9943506,0.0001698252,0.003948631,0.00006343677,0.000008627822,0.0005432001,0.00008173323,0.00000392465,0.0008300443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003590848,"threshold_uncertainty_score":0.007139921,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4394896461","doi":"10.1177/17562864241243186","title":"Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"Chugai Pharmaceutical; Horizon Therapeutics; Genentech; Grifols; Mitsubishi Tanabe Pharma Corporation; Warszawski Uniwersytet Medyczny; CSL Behring; National Institute for Health and Care Research; Regeneron Pharmaceuticals; National Institutes of Health; UCB Pharma; Argenx; Cytokinetics; Japan Blood Products Organization; Union Chimique Belge; Alexion Pharmaceuticals; Patient-Centered Outcomes Research Institute; Biogen; Centers for Disease Control and Prevention; Muscular Dystrophy Association; Uniwersytet Warszawski; Momenta Pharmaceuticals; Sanofi; AstraZeneca; Myasthenia Gravis Foundation of America","keywords":"Medicine; Myasthenia gravis; Interim; Interim analysis; Open label; Term (time); Extension (predicate logic); Adverse effect; Clinical trial; Internal medicine; Law; Computer science","authors":[{"name":"James F. Howard","is_ca":false},{"name":"Saskia Bresch","is_ca":false},{"name":"Constantine Farmakidis","is_ca":false},{"name":"Miriam Freimer","is_ca":false},{"name":"Angela Genge","is_ca":true},{"name":"Channa Hewamadduma","is_ca":false},{"name":"John L. Hinton","is_ca":false},{"name":"Yessar Hussain","is_ca":false},{"name":"Raúl Juntas‐Morales","is_ca":false},{"name":"Henry J. Kaminski","is_ca":false},{"name":"Angelina Maniaol","is_ca":false},{"name":"Renato Mantegazza","is_ca":false},{"name":"Masayuki Masuda","is_ca":false},{"name":"Richard J. Nowak","is_ca":false},{"name":"Kumaraswamy Sivakumar","is_ca":false},{"name":"Marek Śmiłowski","is_ca":false},{"name":"Kimiaki Utsugisawa","is_ca":false},{"name":"Tuan Vu","is_ca":false},{"name":"Michael D. Weiss","is_ca":false},{"name":"Małgorzata Zajda","is_ca":false},{"name":"Jos Bloemers","is_ca":false},{"name":"Babak Boroojerdi","is_ca":false},{"name":"Melissa Brock","is_ca":false},{"name":"Guillemette de la Borderie","is_ca":false},{"name":"Petra W. Duda","is_ca":false},{"name":"Mark Vanderkelen","is_ca":false},{"name":"Maria Isabel Leite","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02397615723265628,"gpt":0.329973967553128,"spread":0.3059978103204717,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005684379,0.0008966543,0.002084227,0.0003028103,0.0003546123,0.001038587,0.0004577808,0.0009342022,0.001862286],"category_scores_gemma":[0.002648648,0.0003200413,0.002496261,0.0002932624,0.0005730964,0.0007756719,0.0003870647,0.002218847,0.0005260321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004784265,"about_ca_system_score_gemma":0.0007127835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002293041,"about_ca_topic_score_gemma":0.000396307,"domain_scores_codex":[0.9987279,0.0006505533,0.00008235847,0.0001538963,0.0001759105,0.0002093705],"domain_scores_gemma":[0.9974733,0.0006914719,0.0008172031,0.0004106738,0.0001685238,0.0004387555],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.871237,0.01102989,0.03795582,0.0003897656,0.003114154,0.0003233093,0.0001966498,0.001867916,0.0160472,0.0001485369,0.001605686,0.05608408],"study_design_scores_gemma":[0.3269103,0.473696,0.1819569,0.00006758914,0.005091327,0.0005293002,0.0001025323,0.002884594,0.005471156,0.0003625881,0.002858564,0.0000691129],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945915,0.001437753,0.0008315084,0.0001497365,0.0000438086,0.0007504907,0.001106208,0.00005894681,0.001030146],"genre_scores_gemma":[0.9946697,0.0003818835,0.0008830855,0.0003243879,0.00008605906,0.0007044635,0.002064765,0.00001431654,0.0008713045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005684379,"threshold_uncertainty_score":0.0300622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3162974988","doi":"10.1177/17562864211014389","title":"A window into the future? MRI for evaluation of neuromyelitis optica spectrum disorder throughout the disease course","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Neuromyelitis optica; Medicine; Disease; Subclinical infection; Spectrum disorder; Magnetic resonance imaging; Multiple sclerosis; Intensive care medicine; Pediatrics; Pathology; Immunology; Radiology; Psychiatry","authors":[{"name":"Jacqueline M. Solomon","is_ca":true},{"name":"Friedemann Paul","is_ca":false},{"name":"Claudia Chien","is_ca":false},{"name":"Jiwon Oh","is_ca":true},{"name":"Dalia Rotstein","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06666058728059476,"gpt":0.4407415941948044,"spread":0.3740810069142096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001050484,0.0007156869,0.001457275,0.003167305,0.000228381,0.001263394,0.000814844,0.001319777,0.00248304],"category_scores_gemma":[0.001921341,0.0002508414,0.0005711698,0.002202792,0.0007100516,0.002037429,0.0005393691,0.002170771,0.001740528],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007623633,"about_ca_system_score_gemma":0.001297247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001694736,"about_ca_topic_score_gemma":0.002571439,"domain_scores_codex":[0.9996126,0.0001134623,0.00007989634,0.00004926366,0.0001197722,0.00002512828],"domain_scores_gemma":[0.9991152,0.0004777816,0.000108311,0.0000234489,0.0002310941,0.00004422043],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008000452,0.00003474066,0.0003294512,0.02081914,0.0001141716,0.0003049065,0.00009339374,0.0001658143,0.0008142678,0.003131088,0.03881435,0.9352987],"study_design_scores_gemma":[0.00002755884,0.000083658,0.001806134,0.02236421,0.0002345779,0.00481611,0.0001595226,0.0001121569,0.0003383186,0.002886858,0.9671387,0.00003219001],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003837735,0.9988698,0.00004909156,0.000486703,0.0001657536,0.000001836542,0.000005969493,0.000003418746,0.0003789924],"genre_scores_gemma":[0.0004367371,0.9984738,0.0001828477,0.000398897,0.0002736975,0.000003706487,0.0000121911,0.000001437578,0.0002167264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003167305,"threshold_uncertainty_score":0.008306623,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3138369521","doi":"10.1177/1756286421998905","title":"Expanding indications for endovascular thrombectomy-how to leave no patient behind","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Thrombolysis; Stroke (engine); Occlusion; Endovascular treatment; Standard of care; Radiology; Intensive care medicine; Surgery; Myocardial infarction; Cardiology","authors":[{"name":"Peter B. Sporns","is_ca":false},{"name":"Jens Fiehler","is_ca":false},{"name":"Johanna M. Ospel","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Uta Hanning","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Mayank Goyal","is_ca":true},{"name":"Ryan McTaggart","is_ca":false},{"name":"Alex Brehm","is_ca":false},{"name":"Marios Psychogios","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04140725659822479,"gpt":0.3576794775090664,"spread":0.3162722209108416,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007660332,0.0006713527,0.001102289,0.002276887,0.0003047861,0.001202647,0.0007042355,0.001210006,0.005073832],"category_scores_gemma":[0.001761844,0.0002155695,0.0007192163,0.001512719,0.0004928659,0.002087442,0.0006294771,0.001777534,0.00175186],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000532468,"about_ca_system_score_gemma":0.001608868,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001224252,"about_ca_topic_score_gemma":0.002763053,"domain_scores_codex":[0.9996427,0.00008477232,0.0001016247,0.00005258771,0.00009310994,0.0000251426],"domain_scores_gemma":[0.9992579,0.0004666469,0.00009853957,0.00001399987,0.0001272985,0.00003564574],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005614901,0.00004140693,0.0002653596,0.03316364,0.00009885009,0.0002764626,0.0001163876,0.0001616491,0.0004984755,0.003745212,0.03752309,0.9240534],"study_design_scores_gemma":[0.00003818642,0.00007206467,0.001517779,0.0534466,0.0003245406,0.002817767,0.0002280629,0.00009764216,0.0001889726,0.00478917,0.9364508,0.00002845741],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009418123,0.9969613,0.0001121152,0.001450696,0.0002971572,0.000005845434,0.00002215472,0.000006500798,0.001050058],"genre_scores_gemma":[0.000499242,0.9980405,0.0002465643,0.0007056519,0.0002350212,0.00000569669,0.00003032927,0.00000185179,0.0002351699],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005073832,"threshold_uncertainty_score":0.01697367,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402890485","doi":"10.1177/17562864241281903","title":"Risk of major adverse cardiovascular events and all-cause mortality under treatment with GLP-1 RAs or the dual GIP/GLP-1 receptor agonist tirzepatide in overweight or obese adults without diabetes: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Liraglutide; Semaglutide; Internal medicine; Mace; Overweight; Odds ratio; Diabetes mellitus; Type 2 diabetes; Placebo; Dulaglutide; Myocardial infarction; Population; Glucagon-like peptide 1 receptor; Endocrinology; Adverse effect; Obesity; Agonist; Receptor; Percutaneous coronary intervention","authors":[{"name":"Maria‐Ioanna Stefanou","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Apostolοs Safouris","is_ca":false},{"name":"Urs Fischer","is_ca":false},{"name":"Peter J. Kelly","is_ca":false},{"name":"Jesse Dawson","is_ca":false},{"name":"Mira Katan","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Vaia Lambadiari","is_ca":false},{"name":"Sotirios Giannopoulos","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Gerasimos Siasos","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06532569228572091,"gpt":0.3519981919897024,"spread":0.2866724997039815,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009750518,0.002198055,0.01686535,0.004553599,0.0004980448,0.00246165,0.00173069,0.001880344,0.002392753],"category_scores_gemma":[0.0201112,0.001417417,0.03493818,0.005267676,0.0006821745,0.001221893,0.001128257,0.001596232,0.0002260653],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001849593,"about_ca_system_score_gemma":0.002382701,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00472371,"about_ca_topic_score_gemma":0.01003448,"domain_scores_codex":[0.9928315,0.003150446,0.002149114,0.0008690209,0.0007894008,0.0002105338],"domain_scores_gemma":[0.9877423,0.007882752,0.002883256,0.0003364208,0.0009629201,0.0001922376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.003353061,0.00003503808,0.005173545,0.3303055,0.6489049,0.0001114954,0.00006143953,0.0005334967,0.000265429,0.00009779723,0.0004576817,0.01070058],"study_design_scores_gemma":[0.0007822851,0.0002040523,0.003376802,0.01446418,0.9798682,0.00008058568,0.00002684651,0.0001623784,0.0001047088,0.0000947939,0.0008166097,0.00001845379],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008736663,0.9896214,0.0003687132,0.000162195,0.0001071628,0.0002005552,0.0005050523,0.00002122672,0.0002769496],"genre_scores_gemma":[0.2326413,0.7626373,0.001652682,0.0008046696,0.0002635738,0.0008364207,0.0008795728,0.00002658576,0.0002579825],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01686535,"threshold_uncertainty_score":0.05156624,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804885025","doi":"10.1177/1756286418774338","title":"Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Multiple sclerosis; Randomized controlled trial; Natalizumab; Relapsing remitting; Clinical trial; Internal medicine; Oncology; Immunology","authors":[{"name":"Bruce Cree","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Mark Cascione","is_ca":false},{"name":"Edward Fox","is_ca":false},{"name":"Ian M. Williams","is_ca":false},{"name":"Xiangyi Meng","is_ca":false},{"name":"Lesley Schofield","is_ca":false},{"name":"Nadia Tenenbaum","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1835123173007922,"gpt":0.4296725863407087,"spread":0.2461602690399164,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004811453,0.002109558,0.003544842,0.0005034035,0.0005738398,0.001345876,0.00123718,0.002331665,0.007203131],"category_scores_gemma":[0.003051906,0.0008863042,0.001911336,0.0004787343,0.001540409,0.001150862,0.0004781781,0.003163628,0.001281888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008004348,"about_ca_system_score_gemma":0.001644527,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006865858,"about_ca_topic_score_gemma":0.0009989005,"domain_scores_codex":[0.9983144,0.001043895,0.00009378723,0.0002613131,0.0001172532,0.000169453],"domain_scores_gemma":[0.9975474,0.0007956634,0.0006210423,0.0002185011,0.0001792521,0.0006381499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9837496,0.008513383,0.0002804201,0.0002369759,0.000447793,0.00001675892,0.00002811252,0.0001457058,0.00167336,0.00004919392,0.0003366159,0.004522165],"study_design_scores_gemma":[0.9526385,0.04591533,0.0004809917,0.00001398472,0.0001712711,0.00001233139,0.000006757482,0.0002762113,0.0002033805,0.0000601674,0.0002142431,0.000006808215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9790224,0.002508364,0.001188503,0.0008569369,0.0007777526,0.01233568,0.001196843,0.0001970005,0.00191655],"genre_scores_gemma":[0.9707587,0.002360058,0.003655962,0.001952269,0.001133083,0.01532924,0.001428429,0.00005496719,0.003327392],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007203131,"threshold_uncertainty_score":0.0254457,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4390639097","doi":"10.1177/17562864231221324","title":"Tenecteplase for the treatment of acute ischemic stroke in the extended time window: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Modified Rankin Scale; Tenecteplase; Odds ratio; Meta-analysis; Thrombolysis; Randomized controlled trial; Confidence interval; Internal medicine; Stroke (engine); Fibrinolytic agent; Relative risk; Tissue plasminogen activator; Ischemic stroke; Ischemia; Myocardial infarction","authors":[{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Guillaume Turc","is_ca":false},{"name":"Michele Romoli","is_ca":false},{"name":"Aikaterini Theodorou","is_ca":false},{"name":"Robin Lemmens","is_ca":false},{"name":"Simona Sacco","is_ca":false},{"name":"Georgios Velonakis","is_ca":false},{"name":"Charalambos Vlachopoulos","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05182824086950986,"gpt":0.3710587875438052,"spread":0.3192305466742953,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009308254,0.00225106,0.01815166,0.005992165,0.0005032075,0.00272714,0.001887953,0.001816476,0.003546323],"category_scores_gemma":[0.01837326,0.001065645,0.02919004,0.006910056,0.0006000955,0.001583441,0.001182774,0.001552015,0.0002563821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002177313,"about_ca_system_score_gemma":0.003616671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005318942,"about_ca_topic_score_gemma":0.01156743,"domain_scores_codex":[0.9946375,0.00231211,0.0016934,0.0005449982,0.0006180855,0.0001938177],"domain_scores_gemma":[0.988304,0.008227693,0.002179091,0.0002700899,0.0008424844,0.0001766371],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00241294,0.00004148107,0.0016121,0.557742,0.4215489,0.0001233103,0.0000689673,0.0004456001,0.0002368585,0.0001322966,0.000562786,0.01507279],"study_design_scores_gemma":[0.0007797143,0.0002634046,0.002309749,0.03607818,0.9581975,0.00009400262,0.00004220551,0.0001580477,0.0001042335,0.0001741395,0.001776469,0.00002222063],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002954634,0.995663,0.0003429569,0.0001447943,0.0001047317,0.0002573151,0.0003328668,0.00001616696,0.000183577],"genre_scores_gemma":[0.08009686,0.9159285,0.001390841,0.0006173528,0.0001916927,0.001027281,0.0005193459,0.00001672406,0.0002115533],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01815166,"threshold_uncertainty_score":0.0492273,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050439782","doi":"10.1177/1756285608101378","title":"Review: Therapeutic options for continuous dopaminergic stimulation in Parkinson's disease","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"","keywords":"Dopaminergic; Dopamine; Levodopa; Medicine; Neuroscience; Parkinson's disease; Stimulation; Dopamine receptor; Dopaminergic pathways; Disease; Pharmacology; Psychology; Internal medicine","authors":[{"name":"O.K. Sujith","is_ca":true},{"name":"Carol J. Lane","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02220645230705962,"gpt":0.3253167809701142,"spread":0.3031103286630545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004023272,0.0007882501,0.0009569086,0.001362684,0.0003171334,0.0006619336,0.0006488975,0.001068818,0.01256653],"category_scores_gemma":[0.0006647228,0.0001425696,0.0003813561,0.001033512,0.0003587409,0.0009583443,0.000369194,0.001133265,0.005766605],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002877443,"about_ca_system_score_gemma":0.0004463937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003588006,"about_ca_topic_score_gemma":0.0008529397,"domain_scores_codex":[0.9998021,0.00007049562,0.00003433274,0.00001921643,0.00005782095,0.00001611138],"domain_scores_gemma":[0.9997335,0.000144797,0.00004012121,0.000007097583,0.0000429836,0.00003142457],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002309666,0.0001630735,0.0001840205,0.01082882,0.00007332188,0.001388305,0.00005590534,0.0001614152,0.004236683,0.001442801,0.09430276,0.8869319],"study_design_scores_gemma":[0.0001189194,0.0002837004,0.001168646,0.002549646,0.0001622766,0.009713968,0.00007781475,0.00008603948,0.001367771,0.001187668,0.9832656,0.0000179452],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004183885,0.9926069,0.0004170944,0.001128859,0.0008466867,0.0000182809,0.0000345992,0.00002203287,0.004507253],"genre_scores_gemma":[0.004607339,0.9867909,0.00135592,0.001517162,0.001581443,0.00003880126,0.00008221405,0.000009130304,0.00401698],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01256653,"threshold_uncertainty_score":0.04203928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4386939132","doi":"10.1177/17562864231194823","title":"Safety and efficacy with alemtuzumab over 13 years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital; University of British Columbia","funders":"Sanofi","keywords":"Medicine; Alemtuzumab; Multiple sclerosis; Relapsing remitting; Topaz; Open label; Oncology; Internal medicine; Adverse effect; Intensive care medicine; Immunology","authors":[{"name":"Alasdair Coles","is_ca":false},{"name":"Anat Achiron","is_ca":false},{"name":"Anthony Traboulsee","is_ca":true},{"name":"B. Singer","is_ca":false},{"name":"Carlo Pozzilli","is_ca":false},{"name":"Celia Oreja‐Guevara","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Gıancarlo Comı","is_ca":false},{"name":"Mark S. Freedman","is_ca":true},{"name":"Tjalf Ziemssen","is_ca":false},{"name":"Débora Shiota","is_ca":false},{"name":"Andreea M. Rawlings","is_ca":false},{"name":"Alana T. Wong","is_ca":false},{"name":"Magdalena Chirieac","is_ca":false},{"name":"Xavier Montalbán","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1193604849736968,"gpt":0.3608530358003331,"spread":0.2414925508266362,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005388438,0.0008610726,0.001417696,0.0003652326,0.0003997901,0.001237516,0.0007357583,0.0008510343,0.001310933],"category_scores_gemma":[0.00296717,0.0002420094,0.001489869,0.0004537475,0.0005386339,0.0008481361,0.000556307,0.001143998,0.0003717143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008114116,"about_ca_system_score_gemma":0.000859846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001641851,"about_ca_topic_score_gemma":0.001412671,"domain_scores_codex":[0.9983974,0.0007763188,0.0001061048,0.0002143565,0.0003258754,0.0001798917],"domain_scores_gemma":[0.996986,0.0004927675,0.001097472,0.0002956601,0.0004235042,0.0007046825],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.744891,0.008454879,0.1270795,0.0007360094,0.007166115,0.0002174911,0.0003753973,0.001891668,0.007368567,0.0001372318,0.003188021,0.09849422],"study_design_scores_gemma":[0.1922805,0.1335819,0.6552495,0.0001111725,0.006785209,0.0004557029,0.0001846142,0.002207945,0.00358771,0.0002516573,0.005206497,0.00009762024],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952502,0.002288564,0.0001926913,0.0001145966,0.00002792767,0.0002275928,0.001250286,0.00003560932,0.000612538],"genre_scores_gemma":[0.9961686,0.000611321,0.000270985,0.0001489204,0.00006956326,0.0001709715,0.002080525,0.00001058459,0.0004685239],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005388438,"threshold_uncertainty_score":0.0284971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4318815070","doi":"10.1177/17562864221150329","title":"Plasma extracellular vesicle tau, β-amyloid, and α-synuclein and the progression of Parkinson’s disease: a follow-up study","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare; Taipei Medical University; Parkinsonfonden; National Taiwan University; National Taiwan University Hospital; Ministry of Science and Technology, Taiwan","keywords":"Medicine; Parkinson's disease; Internal medicine; Biomarker; Disease; Cohort; Alpha-synuclein; Oncology; Endocrinology; Biology","authors":[{"name":"Lung Chan","is_ca":false},{"name":"Chen‐Chih Chung","is_ca":false},{"name":"Yi‐Chen Hsieh","is_ca":false},{"name":"Ruey‐Meei Wu","is_ca":false},{"name":"Chien‐Tai Hong","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01881479634039804,"gpt":0.2950570597293986,"spread":0.2762422633890005,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008766789,0.0005560224,0.0006346218,0.000760163,0.001018943,0.0006577213,0.0004607904,0.0008357168,0.0009598832],"category_scores_gemma":[0.001658014,0.0004728885,0.0007235535,0.0007616578,0.0002464085,0.000682836,0.000514467,0.0009013067,0.0003582755],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004546166,"about_ca_system_score_gemma":0.0004078362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006176249,"about_ca_topic_score_gemma":0.004739297,"domain_scores_codex":[0.9996271,0.00006364544,0.00002916502,0.0001369763,0.00007378804,0.00006931111],"domain_scores_gemma":[0.9989635,0.0001076896,0.0002592043,0.0001547481,0.0002541431,0.0002606626],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001456449,0.0004265741,0.9939063,0.00001611163,0.0002063131,0.0004346419,0.0002050573,0.00004837832,0.0007616485,0.00001169025,0.0001234167,0.002403324],"study_design_scores_gemma":[0.00004120598,0.0007051248,0.9983597,0.000004804233,0.0001035355,0.0003171137,0.00007702661,0.0001057969,0.00009848997,0.00001484941,0.0001678381,0.000004498266],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992197,0.0002117269,0.00008270433,0.00001194405,0.000006669519,0.00002465202,0.0002420286,0.000003698863,0.0001969272],"genre_scores_gemma":[0.9987323,0.0001072141,0.0001184693,0.00002042922,0.00001351589,0.00003083979,0.0006639214,0.000002586764,0.0003106853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006176249,"threshold_uncertainty_score":0.01228064,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889307958","doi":"10.1177/1756286418791143","title":"Long-term outcomes of peginterferon beta-1a in multiple sclerosis: results from the ADVANCE extension study, ATTAIN","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; McGill University; London Health Sciences Centre; NeuroRx Research (Canada)","funders":"Genentech; Biogen","keywords":"Medicine; Tolerability; Multiple sclerosis; Dosing; Adverse effect; Clinical endpoint; Internal medicine; Incidence (geometry); Surgery; Clinical trial","authors":[{"name":"Scott D. Newsome","is_ca":false},{"name":"Thomas F. Scott","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Gereon Nelles","is_ca":false},{"name":"Serena Hung","is_ca":false},{"name":"Yue Cui","is_ca":false},{"name":"Shulian Shang","is_ca":false},{"name":"Maria L. Naylor","is_ca":false},{"name":"Marcelo Kremenchutzky","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1208132788406075,"gpt":0.3691826571197619,"spread":0.2483693782791544,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004290654,0.0005276642,0.0008323982,0.0002582725,0.0002867318,0.0004978934,0.0002947682,0.0005986922,0.001704253],"category_scores_gemma":[0.00204385,0.000160208,0.0009991722,0.0002572649,0.0003482156,0.0005782714,0.0005037087,0.001015895,0.0002892444],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002732495,"about_ca_system_score_gemma":0.0004020634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000271128,"about_ca_topic_score_gemma":0.0004827158,"domain_scores_codex":[0.9993248,0.0003248002,0.0000799979,0.00007718176,0.0001296546,0.0000635625],"domain_scores_gemma":[0.9974542,0.00040303,0.001052206,0.0002133775,0.0002041006,0.0006731573],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7613553,0.01830712,0.09966913,0.001218563,0.003195519,0.0004116248,0.0004468733,0.001844808,0.01107827,0.0002336469,0.00392862,0.09831049],"study_design_scores_gemma":[0.153283,0.2985849,0.5313931,0.0003188886,0.003234117,0.001107192,0.0001485845,0.001062549,0.002773026,0.0002851959,0.007741543,0.00006792317],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938769,0.003516232,0.00015514,0.0001504812,0.00002439896,0.0001874129,0.0009312424,0.00002046885,0.001137762],"genre_scores_gemma":[0.9945627,0.001145544,0.0003891816,0.0002019058,0.0001406373,0.0002067086,0.002540001,0.000006424394,0.0008068982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004290654,"threshold_uncertainty_score":0.02269143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4391053875","doi":"10.1177/17562864231218181","title":"Effect of altered gene expression in lipid metabolism on cognitive improvement in patients with Alzheimer’s dementia following fecal microbiota transplantation: a preliminary study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Research Foundation of Korea; National Research Foundation","keywords":"Dementia; Gut flora; Medicine; Montreal Cognitive Assessment; Cognitive decline; Feces; Transplantation; Microbiome; Clinical Dementia Rating; Internal medicine; Biology; Physiology; Immunology; Bioinformatics; Disease; Microbiology","authors":[{"name":"Jun‐Seob Kim","is_ca":false},{"name":"Hyelim Park","is_ca":false},{"name":"Jung Hwan Lee","is_ca":false},{"name":"Jongbeom Shin","is_ca":false},{"name":"Boram Cha","is_ca":false},{"name":"Kye Sook Kwon","is_ca":false},{"name":"Yong Woon Shin","is_ca":false},{"name":"Yerim Kim","is_ca":false},{"name":"YeoJin Kim","is_ca":false},{"name":"Jong Seok Bae","is_ca":false},{"name":"Ju-Hun Lee","is_ca":false},{"name":"Seok‐Jin Choi","is_ca":false},{"name":"Tae Jung Kim","is_ca":false},{"name":"Sang‐Bae Ko","is_ca":false},{"name":"Soo-Hyun Park","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007089060045650178,"gpt":0.2823228089757372,"spread":0.275233748930087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003687432,0.0003602566,0.0005106095,0.0004591665,0.000302417,0.0003361252,0.0001137351,0.000307296,0.0008670924],"category_scores_gemma":[0.0004074507,0.00009659828,0.0004206705,0.0003140281,0.0002731596,0.000156424,0.0001827234,0.0003386842,0.0001372549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002361491,"about_ca_system_score_gemma":0.0002139379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006181352,"about_ca_topic_score_gemma":0.0008523827,"domain_scores_codex":[0.9998688,0.0000332501,0.00001109277,0.0000345814,0.00002355156,0.00002872287],"domain_scores_gemma":[0.9997466,0.00004409403,0.00006318613,0.00001848477,0.00005182818,0.00007575707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.07044163,0.009814539,0.6356193,0.0003950285,0.0006843907,0.002915694,0.0008432734,0.0002047558,0.2060413,0.0000575003,0.0004264117,0.07255602],"study_design_scores_gemma":[0.0002703537,0.01655928,0.9745515,0.00001199464,0.0002654218,0.0007375712,0.0002497608,0.0002465212,0.006555072,0.0000452212,0.000494741,0.00001248337],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992856,0.0003330383,0.00008082688,0.00001786028,0.000008623005,0.00002017529,0.00006682042,0.000003517699,0.0001836031],"genre_scores_gemma":[0.9989182,0.0002329817,0.0002891606,0.00004365473,0.000019374,0.00003612373,0.0001904585,0.000001467452,0.0002685467],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008670924,"threshold_uncertainty_score":0.00290072,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4285250308","doi":"10.1177/17562864221099472","title":"Effects of low molecular weight heparin and fondaparinux on mortality, hemorrhagic and thrombotic complications in COVID-19 patients","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Fondaparinux; Low molecular weight heparin; Internal medicine; Cochrane Library; Thrombosis; Randomized controlled trial; Meta-analysis; Dosing; Cohort study; Observational study; Venous thromboembolism","authors":[{"name":"Paraskevi C. Fragkou","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Maria‐Ioanna Stefanou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Vaia Lambadiari","is_ca":false},{"name":"Dimitrios Paraskevis","is_ca":false},{"name":"Elisabeth Andreadou","is_ca":false},{"name":"Dimitra Dimopoulou","is_ca":false},{"name":"Christina Zompola","is_ca":false},{"name":"Panagiotis Ferentinos","is_ca":false},{"name":"Theodoros I. Vassilakopoulos","is_ca":false},{"name":"Αναστασία Κοτανίδου","is_ca":false},{"name":"Petros P. Sfikakis","is_ca":false},{"name":"Sotirios Tsiodras","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02498888179868167,"gpt":0.3877964226678904,"spread":0.3628075408692087,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008096433,0.001169508,0.008397521,0.003771174,0.0003925594,0.001930774,0.001126513,0.001551853,0.002104657],"category_scores_gemma":[0.02125696,0.0008007945,0.01831946,0.003420112,0.0005511837,0.000959521,0.0008738093,0.00128984,0.0001266909],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001652801,"about_ca_system_score_gemma":0.002142659,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004167447,"about_ca_topic_score_gemma":0.007614888,"domain_scores_codex":[0.9934378,0.003010179,0.002201302,0.0005677032,0.0006234405,0.0001595316],"domain_scores_gemma":[0.9847177,0.01092238,0.003166977,0.0002500069,0.000731242,0.0002117174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"observational","study_design_scores_codex":[0.01024328,0.0001177688,0.00994042,0.4707794,0.4835576,0.0001264196,0.0001204356,0.0004165678,0.0003729241,0.0001860022,0.0004121189,0.023727],"study_design_scores_gemma":[0.002791536,0.001356211,0.01419817,0.04329531,0.935375,0.0001659215,0.00009910819,0.0002493215,0.0002690956,0.0002951829,0.001870354,0.00003480827],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.01415568,0.9846748,0.0001453857,0.0001569913,0.0001090267,0.0002122369,0.0002650854,0.000006568571,0.0002742299],"genre_scores_gemma":[0.3993588,0.5966638,0.001328014,0.0007617709,0.0002787766,0.0007560659,0.0005934647,0.00001383057,0.0002454259],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.008397521,"threshold_uncertainty_score":0.04281849,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4382995246","doi":"10.1177/17562864231182934","title":"Cardiac therapies for Duchenne muscular dystrophy","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Muscular Dystrophy Canada; Alberta Innovates; Women and Children's Health Research Institute; Children's Health Research Institute","keywords":"Medicine; Duchenne muscular dystrophy; Dystrophin; Intensive care medicine; Disease; Bioinformatics; Cardiomyopathy; Exon skipping; Clinical trial; Muscular dystrophy; Genetic enhancement; Genome editing; CRISPR; Internal medicine; Heart failure; Exon; Gene","authors":[{"name":"Md Nur Ahad Shah","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03475826749725864,"gpt":0.3471559604144085,"spread":0.3123976929171499,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003079506,0.0006109789,0.0008288677,0.001783389,0.0002541486,0.0005921843,0.0005641755,0.000828325,0.005102507],"category_scores_gemma":[0.0003434992,0.0001729823,0.0005688035,0.0008973423,0.0002222542,0.0006190776,0.000535415,0.001816277,0.002075402],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003365817,"about_ca_system_score_gemma":0.0004797043,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005330172,"about_ca_topic_score_gemma":0.001428449,"domain_scores_codex":[0.9998816,0.00001848364,0.00001774177,0.00001903639,0.00005041485,0.00001265101],"domain_scores_gemma":[0.9998858,0.00005959576,0.00001661817,0.000003478019,0.00002380167,0.00001075929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00007553158,0.0001036627,0.00009060453,0.0138198,0.00006947003,0.0003038325,0.00005870771,0.0002936996,0.004103178,0.002811485,0.0250252,0.9532449],"study_design_scores_gemma":[0.00002394851,0.0001365337,0.000674438,0.003465137,0.0001033782,0.001594782,0.00003159383,0.00007562569,0.0009122365,0.001264564,0.9917035,0.00001428343],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002368227,0.9974476,0.0001912306,0.0002026249,0.0002028594,0.000007384413,0.00002865398,0.00001200066,0.001670886],"genre_scores_gemma":[0.001108882,0.996904,0.0003101823,0.000253505,0.0001194075,0.00001151905,0.00006375707,0.00000301429,0.001225653],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005102507,"threshold_uncertainty_score":0.01706964,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W145182321","doi":"10.1177/1756285608098359","title":"Review: Escalating immunotherapy of multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Natalizumab; Glatiramer acetate; Alemtuzumab; Multiple sclerosis; Mitoxantrone; Immunotherapy; Clinical trial; Disease; Intensive care medicine; Fingolimod; Oncology; Immunosuppression; Immunology; Internal medicine; Transplantation; Chemotherapy; Immune system","authors":[{"name":"Anthony Traboulsee","is_ca":true},{"name":"Virginia Devonshire","is_ca":true},{"name":"Joël Oger","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08269379223139042,"gpt":0.3385518491725664,"spread":0.2558580569411759,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001590322,0.001243449,0.00287433,0.002374278,0.0003427333,0.001533407,0.001521611,0.001971192,0.006886983],"category_scores_gemma":[0.004078671,0.000278405,0.0008677556,0.003612505,0.0006303375,0.001736726,0.0005313121,0.001572464,0.002474236],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001133863,"about_ca_system_score_gemma":0.001499962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001329439,"about_ca_topic_score_gemma":0.002332859,"domain_scores_codex":[0.9988528,0.0004164991,0.0002412522,0.0001073082,0.0003434868,0.00003851537],"domain_scores_gemma":[0.9982811,0.001014629,0.0002884264,0.00003385517,0.0002954947,0.00008648865],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004582516,0.00008156672,0.000203857,0.1140427,0.000638461,0.0003501956,0.00006610397,0.0003606163,0.0007129809,0.001202054,0.130253,0.7516302],"study_design_scores_gemma":[0.0003890713,0.0003863949,0.002159613,0.05365296,0.001428317,0.002610088,0.0001208425,0.0001336524,0.0004191344,0.001973945,0.9366904,0.00003557799],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001042276,0.9969968,0.00009759401,0.000629786,0.001171048,0.00004148766,0.0000280658,0.000007294165,0.0009237976],"genre_scores_gemma":[0.0007330935,0.996406,0.0002582238,0.001273956,0.0006951428,0.00003765034,0.00003944623,0.000002067117,0.0005543674],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006886983,"threshold_uncertainty_score":0.02303928,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3089064542","doi":"10.1177/1756286420954083","title":"Standardized algorithm for muscle selection and dosing of botulinum toxin for Parkinson tremor using kinematic analysis","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"London Health Sciences Centre; Lawson Health Research Institute; Western University","funders":"Merz Pharmaceuticals","keywords":"Medicine; Dosing; Botulinum toxin; Rating scale; Physical medicine and rehabilitation; Essential tremor; Quality of life (healthcare); Grip strength; Weakness; Physical therapy; Anesthesia; Internal medicine; Psychology; Surgery","authors":[{"name":"Olivia Samotus","is_ca":true},{"name":"Mandar Jog","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03389466039749872,"gpt":0.3268518546039901,"spread":0.2929571942064914,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006070277,0.001367981,0.001203662,0.00216747,0.0003839301,0.001296903,0.0009723971,0.0006127794,0.002925217],"category_scores_gemma":[0.01727978,0.0004142079,0.0007207313,0.0009980995,0.0003775834,0.0004701855,0.0009797688,0.0008911084,0.001520107],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008644015,"about_ca_system_score_gemma":0.002182417,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002308979,"about_ca_topic_score_gemma":0.002896033,"domain_scores_codex":[0.9952849,0.001693442,0.0007609169,0.0008547362,0.00126603,0.0001400577],"domain_scores_gemma":[0.9938006,0.00170138,0.001255217,0.0006195593,0.00245777,0.000165546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005838855,0.001015133,0.06530083,0.0005050672,0.0004771237,0.0003168161,0.0003448553,0.02938923,0.04861235,0.001663453,0.01432596,0.8322104],"study_design_scores_gemma":[0.003863419,0.006011795,0.1525063,0.0003819405,0.0008162694,0.00273953,0.0002680916,0.6997505,0.08267501,0.007273318,0.04328734,0.0004265273],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.0713187,0.0006430126,0.9093623,0.0004111648,0.0001543324,0.005592777,0.001966587,0.007287812,0.003263316],"genre_scores_gemma":[0.2043073,0.0002950189,0.7848014,0.0002720188,0.00007963372,0.005641545,0.002743911,0.000444528,0.001414677],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.006070277,"threshold_uncertainty_score":0.03210306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310782882","doi":"10.1177/17562864221139632","title":"Endovascular treatment for anterior circulation large-vessel occlusion ischemic stroke with low ASPECTS: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Meta-analysis; Modified Rankin Scale; Stroke (engine); MEDLINE; Systematic review; Ischemic stroke; Randomized controlled trial; Internal medicine; Clinical trial; Ischemia","authors":[{"name":"Apostolοs Safouris","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"István Szikora","is_ca":false},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"George Magoufis","is_ca":false},{"name":"Klearchos Psychogios","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Εlias Brountzos","is_ca":false},{"name":"Sándor Nardai","is_ca":false},{"name":"Nitin Goyal","is_ca":false},{"name":"Diana Aguiar de Sousa","is_ca":false},{"name":"Daniel Strbian","is_ca":false},{"name":"Valeria Caso","is_ca":false},{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04180377092369003,"gpt":0.3360274067380769,"spread":0.2942236358143869,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01089936,0.00277895,0.0196688,0.007061103,0.000610158,0.003049252,0.002105181,0.002268563,0.003260061],"category_scores_gemma":[0.0228255,0.001413489,0.03900057,0.007495451,0.0006343606,0.001552755,0.001325984,0.001625958,0.0003099754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002013075,"about_ca_system_score_gemma":0.00297837,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005543757,"about_ca_topic_score_gemma":0.01197316,"domain_scores_codex":[0.9925687,0.003542337,0.002123497,0.0007491,0.0007410678,0.0002752062],"domain_scores_gemma":[0.9860454,0.009743209,0.002430805,0.0004613863,0.00111115,0.0002079791],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001609899,0.00003127841,0.003053015,0.3278226,0.6580018,0.0001132203,0.00006179279,0.0004511973,0.0001689481,0.00008941374,0.0004342573,0.008162543],"study_design_scores_gemma":[0.000350823,0.0001368565,0.002504683,0.01696795,0.9787872,0.0000678158,0.00002909664,0.0001276927,0.00006338362,0.00009990938,0.0008491653,0.00001542043],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004582391,0.9938846,0.0004489929,0.0001529035,0.0001163547,0.0002090391,0.0003910869,0.00001900728,0.0001956182],"genre_scores_gemma":[0.1499725,0.8446669,0.002119646,0.0007229953,0.0003197918,0.00102699,0.0008835741,0.00002568853,0.0002621028],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0196688,"threshold_uncertainty_score":0.05764198,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2922749437","doi":"10.1177/1756286419835708","title":"Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Medicine; Modified Rankin Scale; Confounding; Logistic regression; Stroke (engine); Odds ratio; Confidence interval; Internal medicine; Clinical trial; Surgery; Ischemic stroke; Ischemia","authors":[{"name":"Thomas R. Meinel","is_ca":false},{"name":"Johannes Kaesmacher","is_ca":false},{"name":"Pasquale Mordasini","is_ca":false},{"name":"Pascal J. Mosimann","is_ca":false},{"name":"Simon Jung","is_ca":false},{"name":"Marcel Arnold","is_ca":false},{"name":"Mirjam R. Heldner","is_ca":false},{"name":"Patrik Michel","is_ca":false},{"name":"Steven Hajdu","is_ca":false},{"name":"Marc Ribó","is_ca":false},{"name":"Manuel Requena","is_ca":false},{"name":"Christian Maegerlein","is_ca":false},{"name":"Benjamin Friedrich","is_ca":false},{"name":"Vincent Costalat","is_ca":false},{"name":"Amel Benali","is_ca":false},{"name":"Laurent Pierot","is_ca":true},{"name":"Matthias Gawlitza","is_ca":false},{"name":"Joanna D. Schaafsma","is_ca":true},{"name":"Vítor Mendes Pereira","is_ca":true},{"name":"Jan Gralla","is_ca":false},{"name":"Urs Fischer","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02135443875503519,"gpt":0.3062179837653848,"spread":0.2848635450103496,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003421455,0.0003934928,0.0006717258,0.001243755,0.0002933205,0.0007810393,0.0007580962,0.0006593955,0.0008505665],"category_scores_gemma":[0.009009808,0.0003307882,0.001060311,0.002395451,0.0003466861,0.0007145978,0.0007301282,0.0005891316,0.0002124271],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004259258,"about_ca_system_score_gemma":0.0005120499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003270515,"about_ca_topic_score_gemma":0.002966755,"domain_scores_codex":[0.9964067,0.001464565,0.0007072501,0.0006327662,0.0005217557,0.0002669016],"domain_scores_gemma":[0.9847332,0.002425765,0.009912456,0.001372585,0.0007905726,0.0007653637],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000573679,0.00003203156,0.9981273,0.00001979242,0.0002364193,0.00003695762,0.00003244643,0.00009993061,0.00008279501,0.00001259781,0.0001448877,0.0006011743],"study_design_scores_gemma":[0.00005168128,0.0001017533,0.9991838,0.000005939371,0.0001054986,0.0001407267,0.00003248156,0.0002599562,0.00003734567,0.0000161762,0.00005919312,0.000005323338],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978517,0.0002538709,0.0001262782,0.00004608849,0.000005762828,0.00001249105,0.001564835,0.000005455194,0.0001334397],"genre_scores_gemma":[0.9978294,0.0001071937,0.0001058043,0.00002156319,0.00001732813,0.00002807017,0.001848584,0.000003208887,0.00003890391],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003421455,"threshold_uncertainty_score":0.0180946,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4226062860","doi":"10.1177/17562864211058298","title":"Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"EMD Serono; MedDay Pharmaceuticals; Genentech; Serono Symposia International Foundation; Servier; Aristotle University of Thessaloniki; Pirogov Russian National Research Medical University; Medizinische Universität Wien; Rigshospitalet; Università degli Studi di Genova; Hebrew University of Jerusalem; Universität Wien; Queen Mary University of London; CSL Behring; Gentofte Hospital; Fresenius Medical Care North America; Five Prime Therapeutics; Ironwood Pharmaceuticals, Incorporated; Vertex Pharmaceuticals; Ottawa Hospital Research Institute; Bayer Vital; Bristol-Myers Squibb; Bundesministerium für Bildung und Forschung; Atara Biotherapeutics; Merck KGaA; Univerzita Karlova v Praze; Pfizer; Biogen; Celgene; Teva Pharmaceutical Industries; Sanofi; GW Pharmaceuticals; Università degli Studi di Napoli Federico II; Bayer HealthCare; Deutsche Forschungsgemeinschaft; Directorate for Biological Sciences; GlaxoSmithKline","keywords":"Cladribine; Medicine; Expert opinion; Vaccination; Coronavirus disease 2019 (COVID-19); Clinical Practice; Dosing; MEDLINE; Multiple sclerosis; Family medicine; Intensive care medicine; Pharmacology; Internal medicine; Pathology; Immunology; Disease; Infectious disease (medical specialty)","authors":[{"name":"Diego Centonze","is_ca":false},{"name":"Gavin Giovannoni","is_ca":false},{"name":"Le H. Hua","is_ca":false},{"name":"Celia Oreja‐Guevara","is_ca":false},{"name":"Daniel Selchen","is_ca":true},{"name":"Per Soelberg Sørensen","is_ca":false},{"name":"Patrick Vermersch","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Hashem Salloukh","is_ca":false},{"name":"Bassem Yamout","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3187153313532363,"gpt":0.5275843612080184,"spread":0.2088690298547822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1315792,0.001059415,0.002314884,0.004180183,0.001698493,0.004742271,0.005417064,0.01505625,0.006046822],"category_scores_gemma":[0.3006422,0.001009022,0.003473654,0.003339917,0.002806859,0.004158759,0.005152978,0.009009349,0.003216819],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005387257,"about_ca_system_score_gemma":0.02824574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003553326,"about_ca_topic_score_gemma":0.003491802,"domain_scores_codex":[0.8250086,0.09556503,0.04417398,0.005548409,0.02602924,0.003674609],"domain_scores_gemma":[0.5991156,0.1746227,0.03400208,0.006424023,0.1722912,0.01354438],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004695799,0.0001524929,0.004641457,0.033174,0.000893531,0.001327451,0.006360913,0.001434758,0.001826011,0.006751625,0.5708927,0.3720755],"study_design_scores_gemma":[0.0003740803,0.0002744531,0.003517507,0.08575629,0.0009597664,0.001310395,0.004652513,0.001498608,0.0009807644,0.01512664,0.8853227,0.0002264112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.00722045,0.123658,0.01617299,0.772674,0.04206736,0.002073233,0.001208445,0.000183915,0.03474165],"genre_scores_gemma":[0.2168785,0.2517527,0.1338226,0.3353083,0.0375441,0.005425471,0.003594156,0.0002525749,0.01542147],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1315792,"threshold_uncertainty_score":0.6958658,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168568690","doi":"10.1177/1756285614549554","title":"Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome","year":2014,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Bayer HealthCare","keywords":"Medicine; Multiple sclerosis; Clinically isolated syndrome; Interferon beta-1b; Placebo; Expanded Disability Status Scale; Magnetic resonance imaging; Internal medicine; McDonald criteria; Randomization; Clinical trial; Interferon beta-1a; Interferon beta; Gastroenterology; Pathology; Immunology; Radiology","authors":[{"name":"Mark S. Freedman","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2568097306530227,"gpt":0.4393229827033321,"spread":0.1825132520503094,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001913317,0.0006132681,0.002361169,0.001728314,0.0001669607,0.0007165467,0.0009289462,0.0009209048,0.003399175],"category_scores_gemma":[0.002971452,0.0003135665,0.001285714,0.002125867,0.0004101211,0.0005244134,0.0004478039,0.0008777798,0.0005083556],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005866938,"about_ca_system_score_gemma":0.001458068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001591074,"about_ca_topic_score_gemma":0.002616241,"domain_scores_codex":[0.9995108,0.0001746729,0.000133238,0.00005074769,0.0001109738,0.00001963474],"domain_scores_gemma":[0.9981815,0.001260347,0.000301456,0.0000251826,0.0001843772,0.00004732987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001820277,0.00009095567,0.0004052605,0.2697361,0.002987974,0.0001560899,0.00009282713,0.0001598256,0.001216065,0.001196813,0.009629086,0.7125087],"study_design_scores_gemma":[0.002899998,0.002493469,0.01654878,0.2711085,0.03682418,0.002842373,0.0004145278,0.0003278414,0.003016157,0.00278097,0.6606447,0.00009861126],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001894881,0.9995176,0.0000117967,0.00007103474,0.00002965953,0.00000524713,0.0000153539,0.000001323854,0.0001585954],"genre_scores_gemma":[0.002252922,0.9974385,0.0000715436,0.0001114922,0.00002534048,0.000008013842,0.00002597493,6.819632e-7,0.00006558676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003399175,"threshold_uncertainty_score":0.01137131,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4380785062","doi":"10.1177/17562864231180715","title":"Arterial stiffness and its influence on cerebral morphology and cognitive function","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alzheimer Society","keywords":"Arterial stiffness; Medicine; Pulse wave velocity; Cardiology; Hyperintensity; Internal medicine; Blood pressure; Dementia; Ambulatory blood pressure; Pulse pressure; Magnetic resonance imaging; Disease; Radiology","authors":[{"name":"Melanie Haidegger","is_ca":false},{"name":"Simon Lindenbeck","is_ca":false},{"name":"Edith Hofer","is_ca":false},{"name":"Christina Rodler","is_ca":false},{"name":"Robert Zweiker","is_ca":false},{"name":"Sabine Perl","is_ca":false},{"name":"Lukas Pirpamer","is_ca":false},{"name":"Markus Kneihsl","is_ca":false},{"name":"Simon Fandler‐Höfler","is_ca":false},{"name":"Thomas Gattringer","is_ca":false},{"name":"Christian Enzinger","is_ca":false},{"name":"Reinhold Schmidt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01798120612956853,"gpt":0.3056240441426175,"spread":0.287642838013049,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003807886,0.0002685358,0.0002043847,0.0005422229,0.0001429086,0.0003514421,0.0001375244,0.0002448733,0.001379034],"category_scores_gemma":[0.002031058,0.0001250693,0.0002054433,0.0004013287,0.0002063764,0.0001379677,0.0001802625,0.0003419973,0.0001758787],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001374521,"about_ca_system_score_gemma":0.0001595481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001130496,"about_ca_topic_score_gemma":0.001197998,"domain_scores_codex":[0.999821,0.00006666355,0.00001150275,0.00003440406,0.00003396053,0.00003247835],"domain_scores_gemma":[0.9985284,0.0004983175,0.0005790316,0.00009231811,0.0001201439,0.0001818898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001821868,0.0001808615,0.9779675,0.00005909915,0.0002713955,0.000377209,0.0001261058,0.0001744495,0.005573815,0.0000537751,0.0001226047,0.01327132],"study_design_scores_gemma":[0.000003653161,0.0001278652,0.9992552,0.000003445062,0.00002244565,0.0002384618,0.00001220298,0.0001151198,0.0001397774,0.00003514529,0.00004482159,0.000001863554],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985948,0.0008314867,0.00009456254,0.00002700594,0.000005615405,0.000003109656,0.00009820464,0.000003741265,0.0003415368],"genre_scores_gemma":[0.9994779,0.000215439,0.0001052492,0.000008360586,0.00001568878,0.00000278019,0.00007101526,0.000001546889,0.0001020199],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001379034,"threshold_uncertainty_score":0.00461334,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2956892819","doi":"10.1177/1756286419860652","title":"Endovascular equipoise shift in a phase III randomized clinical trial of sonothrombolysis for acute ischemic stroke","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Ultrasound and Hyperthermia Applications","field":"Engineering","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Randomized controlled trial; Odds ratio; Thrombolysis; Clinical trial; Clinical equipoise; Stroke (engine); Population; Post-hoc analysis; Internal medicine; Physical therapy; Myocardial infarction","authors":[{"name":"Andrei V. Alexandrov","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false},{"name":"Martin Köhrmann","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":false},{"name":"Lauri Soinne","is_ca":false},{"name":"Andrew D. Barreto","is_ca":false},{"name":"Travis Rothlisberger","is_ca":false},{"name":"Vijay K. Sharma","is_ca":false},{"name":"Robert Mikulík","is_ca":false},{"name":"Keith W. Muir","is_ca":false},{"name":"Christopher Levi","is_ca":false},{"name":"Carlos A. Molina","is_ca":false},{"name":"Maher Saqqur","is_ca":true},{"name":"Dimitris Mavridis","is_ca":false},{"name":"Θεοδώρα Ψαλτοπούλου","is_ca":false},{"name":"Milan R. Voško","is_ca":false},{"name":"Jochen B. Fiebach","is_ca":false},{"name":"Pitchaiah Mandava","is_ca":false},{"name":"Thomas A. Kent","is_ca":false},{"name":"Peter D. Schellinger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01854891062198567,"gpt":0.3288484960183792,"spread":0.3102995853963935,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01276126,0.001129067,0.001964875,0.0003730864,0.0003283319,0.001184137,0.0005786339,0.001461609,0.002348733],"category_scores_gemma":[0.01217963,0.0004916305,0.002753678,0.0004118553,0.001064644,0.0007367588,0.0005904461,0.001701958,0.0003013501],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005276577,"about_ca_system_score_gemma":0.001343202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002735936,"about_ca_topic_score_gemma":0.0004241895,"domain_scores_codex":[0.9835084,0.01398204,0.0007454295,0.0007357364,0.0005634054,0.0004649463],"domain_scores_gemma":[0.9908327,0.005089208,0.002045613,0.0007490753,0.0003690891,0.0009141463],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9859702,0.00292632,0.002289361,0.0002316633,0.002338655,0.00002424748,0.00006216751,0.0002778889,0.001123306,0.00008424261,0.0001450726,0.004526874],"study_design_scores_gemma":[0.898666,0.08915874,0.008460787,0.00003310162,0.001492776,0.00003849839,0.00002342732,0.0008888355,0.0005938729,0.0002707377,0.0003543303,0.0000189189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.992328,0.00175677,0.001801413,0.0004276988,0.0002931247,0.002558263,0.0001839394,0.00004769466,0.0006030629],"genre_scores_gemma":[0.9947967,0.0003255541,0.001475633,0.0004906021,0.0002257612,0.002206882,0.0001954755,0.000008440678,0.0002749376],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01276126,"threshold_uncertainty_score":0.06748885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2737414819","doi":"10.1177/1756285617722352","title":"Liver injury and glatiramer acetate, an uncommon association: case report and literature review","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Neurological Disorders","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alberta Innovates - Health Solutions; Biogen; Sanofi","keywords":"Medicine; Glatiramer acetate; Autoimmune hepatitis; Discontinuation; Liver injury; Magnetic resonance imaging; Liver function; Lesion; Multiple sclerosis; Liver biopsy; Past medical history; Hepatitis; Radiology; Gastroenterology; Internal medicine; Surgery; Biopsy; Immunology","authors":[{"name":"Núria Solà‐Valls","is_ca":false},{"name":"Elisa Pose","is_ca":false},{"name":"Yolanda Blanco","is_ca":false},{"name":"María Sepúlveda","is_ca":false},{"name":"Sara Llufriú","is_ca":false},{"name":"Pere Ginès","is_ca":false},{"name":"Albert Saiz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1752683675166538,"gpt":0.4995301537817736,"spread":0.3242617862651198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003047013,0.0008652614,0.001089973,0.004726815,0.000569811,0.001215643,0.0008731189,0.001384874,0.002622648],"category_scores_gemma":[0.001128035,0.0003297884,0.0004859311,0.004390698,0.0006854466,0.001751008,0.0007759912,0.0009246524,0.001060574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000329455,"about_ca_system_score_gemma":0.001086388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009491023,"about_ca_topic_score_gemma":0.00165428,"domain_scores_codex":[0.9996865,0.00004051907,0.0001183726,0.00006127177,0.00006060074,0.00003271519],"domain_scores_gemma":[0.9990553,0.000405758,0.0003337207,0.000038144,0.0001015789,0.00006547004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"case_report","study_design_scores_codex":[0.0001542876,0.0002179672,0.01428534,0.04125156,0.0004443833,0.1696027,0.0009087527,0.0005343611,0.00371578,0.002427138,0.04074971,0.7257079],"study_design_scores_gemma":[0.00002445898,0.0001011681,0.009538295,0.008767312,0.0005654206,0.7076375,0.000791494,0.0001701031,0.000888968,0.001792183,0.2696662,0.00005677194],"study_design_candidate":"case_report","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002302744,0.9956392,0.0001627564,0.000309056,0.0001838947,0.000008225405,0.00003633031,0.00001371438,0.001344126],"genre_scores_gemma":[0.01658749,0.9811288,0.0004003423,0.000469039,0.000832841,0.00001030116,0.00009398117,0.000005127032,0.0004720537],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004726815,"threshold_uncertainty_score":0.008773565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402546568","doi":"10.1177/17562864241273036","title":"Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"EMD Serono; Schweizerische Multiple Sklerose Gesellschaft; F. Hoffmann-La Roche; Grifols; Fondazione Cariplo; Multiple Sclerosis Society; UCB Pharma; Argenx; Idorsia Pharmaceuticals; Amicus Therapeutics; Janssen Pharmaceuticals; Merck KGaA; Bristol-Myers Squibb; CSL Behring; Pfizer; Biogen; Celgene; H. Lundbeck A/S; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Regeneron Pharmaceuticals; Novo Nordisk; Teva Pharmaceutical Industries; Sanofi","keywords":"Medicine; Myasthenia gravis; Autoantibody; Placebo; Subgroup analysis; Internal medicine; Tyrosine kinase; Gastroenterology; Antibody; Immunology; Oncology; Pharmacology; Meta-analysis; Receptor; Pathology; Alternative medicine","authors":[{"name":"Ali A. Habib","is_ca":false},{"name":"Sabrina Sacconi","is_ca":false},{"name":"Giovanni Antonini","is_ca":false},{"name":"Elena Cortés‐Vicente","is_ca":false},{"name":"Julian Großkreutz","is_ca":false},{"name":"Zabeen Mahuwala","is_ca":false},{"name":"Renato Mantegazza","is_ca":false},{"name":"Robert M. Pascuzzi","is_ca":false},{"name":"Kimiaki Utsugisawa","is_ca":false},{"name":"John Vissing","is_ca":false},{"name":"Tuan Vu","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Marion Boehnlein","is_ca":false},{"name":"Bernhard Greve","is_ca":false},{"name":"Franz Woltering","is_ca":false},{"name":"Vera Bril","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01523250983793078,"gpt":0.2854096034517853,"spread":0.2701770936138545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003762526,0.001517589,0.005021396,0.0004876284,0.0003530476,0.001220695,0.000744805,0.001510981,0.002665304],"category_scores_gemma":[0.002995464,0.000617617,0.005363937,0.0004252367,0.0006909865,0.0007959434,0.0004303156,0.001648257,0.0004687434],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007100371,"about_ca_system_score_gemma":0.0008050968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005687911,"about_ca_topic_score_gemma":0.001805098,"domain_scores_codex":[0.9983467,0.0009607796,0.0002213674,0.0001995023,0.0001137743,0.0001578973],"domain_scores_gemma":[0.9984537,0.0005849996,0.0004106265,0.0001840355,0.0001001547,0.0002664755],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9723717,0.001022899,0.001922018,0.0009670738,0.006517217,0.00006670137,0.00005727196,0.0003615957,0.004092637,0.00004393837,0.0002986609,0.01227822],"study_design_scores_gemma":[0.9203565,0.0599661,0.010012,0.00008326486,0.00765278,0.00009117303,0.0000521089,0.0005019751,0.0005407671,0.0001597292,0.000550243,0.00003344913],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9804391,0.01467592,0.0006566597,0.000430726,0.0003043796,0.001629994,0.0007636769,0.00006165297,0.001037892],"genre_scores_gemma":[0.9951265,0.002141591,0.0004157294,0.0003694519,0.0001957828,0.0007982232,0.0004790595,0.00001183986,0.0004617718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005021396,"threshold_uncertainty_score":0.01989841,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2889527974","doi":"10.1177/1756286418795085","title":"Peginterferon β-1a every 2 weeks increased achievement of no evidence of disease activity over 4 years in the ADVANCE and ATTAIN studies in patients with relapsing–remitting multiple sclerosis","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Biogen","keywords":"Medicine; Multiple sclerosis; Predictive value; Clinical disease; Magnetic resonance imaging; Internal medicine; Disease; Cardiology; Gastroenterology; Radiology; Immunology","authors":[{"name":"Douglas L. Arnold","is_ca":true},{"name":"Shulian Shang","is_ca":false},{"name":"Qunming Dong","is_ca":false},{"name":"Matthias Meergans","is_ca":false},{"name":"Maria L. Naylor","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06831757290086274,"gpt":0.3485683056196654,"spread":0.2802507327188026,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002408876,0.0005494305,0.001179584,0.0002552893,0.0001729585,0.0005272409,0.000215369,0.0004688668,0.00102634],"category_scores_gemma":[0.001998496,0.0002643419,0.001018566,0.0002423867,0.0002902826,0.0006821992,0.000553015,0.001110229,0.0001068082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003119022,"about_ca_system_score_gemma":0.0003062101,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000326668,"about_ca_topic_score_gemma":0.0008125714,"domain_scores_codex":[0.9993082,0.0003596612,0.0000609724,0.0001145909,0.00009239146,0.00006409077],"domain_scores_gemma":[0.9983093,0.000401867,0.0007051309,0.0001314419,0.00009762394,0.000354678],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7361583,0.007979833,0.1482288,0.0007522194,0.002481781,0.0002796656,0.0005511317,0.001982978,0.02450714,0.0002260242,0.00102722,0.07582493],"study_design_scores_gemma":[0.05180367,0.3378592,0.5926143,0.0001295636,0.002930244,0.0007597327,0.0001847281,0.002699906,0.006277531,0.0002660409,0.004385525,0.00008957966],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982758,0.001087259,0.00006810168,0.00004701026,0.00001585556,0.00003493639,0.00008797232,0.000007244661,0.0003758309],"genre_scores_gemma":[0.9986959,0.0003582917,0.0002514435,0.00004998651,0.000042163,0.00003759272,0.0001940357,0.000002021826,0.00036855],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002408876,"threshold_uncertainty_score":0.01273954,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4396242288","doi":"10.1177/17562864241246938","title":"Overview of systematic reviews comparing endovascular to best medical treatment for large-vessel occlusion acute ischaemic stroke: an umbrella review","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Randomized controlled trial; Modified Rankin Scale; Systematic review; Meta-analysis; MEDLINE; Confidence interval; Relative risk; Stroke (engine); Cochrane Library; Internal medicine; Physical therapy; Ischemic stroke; Ischemia","authors":[{"name":"Apostolοs Safouris","is_ca":false},{"name":"Lina Palaiodimou","is_ca":false},{"name":"Aristeidis H. Katsanos","is_ca":true},{"name":"Odysseas Kargiotis","is_ca":false},{"name":"Konstantinos I. Bougioukas","is_ca":false},{"name":"Klearchos Psychogios","is_ca":false},{"name":"Tatiana Sidiropoulou","is_ca":false},{"name":"Stavros Spiliοpoulos","is_ca":false},{"name":"Marios‐Nikos Psychogios","is_ca":false},{"name":"Georgios Magoufis","is_ca":false},{"name":"Guillaume Turc","is_ca":false},{"name":"Georgios Tsivgoulis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0994132575965261,"gpt":0.4083583960650873,"spread":0.3089451384685613,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01778151,0.002868745,0.01348791,0.02401739,0.000925571,0.003777365,0.002295726,0.00260331,0.005958187],"category_scores_gemma":[0.06861745,0.001897516,0.00999226,0.01843612,0.001199518,0.003634976,0.002466769,0.00159901,0.0007101017],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005367777,"about_ca_system_score_gemma":0.01266017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005908223,"about_ca_topic_score_gemma":0.01673301,"domain_scores_codex":[0.9785033,0.00816772,0.008284843,0.001372099,0.003233816,0.0004382855],"domain_scores_gemma":[0.9524146,0.03296062,0.009736437,0.0007615483,0.00371099,0.0004158629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.000102828,0.000007933521,0.0002371528,0.9674489,0.007478949,0.00004413529,0.00009069966,0.00007038393,0.0001171241,0.0003047354,0.001897017,0.02220016],"study_design_scores_gemma":[0.0001254095,0.0001109432,0.001435288,0.9219626,0.05228883,0.0001562384,0.0001086174,0.00007457185,0.0001321208,0.0005199757,0.02305966,0.0000255805],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002285636,0.9980502,0.0002286693,0.0003853953,0.0001659206,0.0003662372,0.0003321264,0.00001186136,0.0002310341],"genre_scores_gemma":[0.004488757,0.9918565,0.001119692,0.0007267179,0.0001708541,0.001222395,0.0002748629,0.00000943411,0.0001308933],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02401739,"threshold_uncertainty_score":0.09403872,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392848466","doi":"10.1177/17562864241233044","title":"Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Research Manitoba; Multiple Sclerosis Trust; Multiple Sclerosis Society of Canada; Arthritis Society; Alexion Pharmaceuticals; Celgene; Biogen; Gemeinsame Bundesausschuss; Sanofi; U.S. Department of Defense","keywords":"Medicine; Multiple sclerosis; Observational study; Fingolimod; Disease; Proportional hazards model; Patient registry; Internal medicine; Adverse effect; Pediatrics; Emergency medicine; Immunology","authors":[{"name":"Alexander Stahmann","is_ca":false},{"name":"Elaine Craig","is_ca":false},{"name":"David Ellenberger","is_ca":false},{"name":"Firas Fneish","is_ca":false},{"name":"Niklas Frahm","is_ca":false},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Rod Middleton","is_ca":false},{"name":"Richard Nicholas","is_ca":false},{"name":"Jeff Rodgers","is_ca":false},{"name":"Clemens Warnke","is_ca":false},{"name":"Amber Salter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1704735167555629,"gpt":0.3773027207272071,"spread":0.2068292039716443,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02375936,0.001179333,0.002715369,0.004219159,0.0004169013,0.002152315,0.00129905,0.001073569,0.0007771752],"category_scores_gemma":[0.02519504,0.0009328689,0.01642832,0.005624161,0.0005064708,0.0008293786,0.001533127,0.000974494,0.0001005386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00113391,"about_ca_system_score_gemma":0.001355962,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01037018,"about_ca_topic_score_gemma":0.01024024,"domain_scores_codex":[0.9887652,0.005955057,0.002028479,0.001887048,0.001023853,0.0003404155],"domain_scores_gemma":[0.9789844,0.01047416,0.007413188,0.001612192,0.001122629,0.000393542],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.006111731,0.0001274461,0.7853639,0.004673096,0.1883366,0.000139153,0.0003889867,0.0009767705,0.0003189112,0.0001724471,0.0004670133,0.01292398],"study_design_scores_gemma":[0.00152629,0.001067609,0.7883811,0.001254028,0.2032055,0.0003690786,0.000395443,0.0017547,0.000350528,0.0004405923,0.001187999,0.00006707929],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8595734,0.1338503,0.002028631,0.0003365173,0.0001060478,0.0002197091,0.003137286,0.00007096408,0.000677134],"genre_scores_gemma":[0.9894078,0.008028136,0.000914202,0.0001106262,0.00004062821,0.0001498794,0.001276587,0.00001300772,0.0000591674],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02375936,"threshold_uncertainty_score":0.125653,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4412808922","doi":"10.1177/17562864251351760","title":"Clinical and mechanistic effects of cladribine in relapsing multiple sclerosis: 2-year results from the MAGNIFY-MS Study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Rheinische Friedrich-Wilhelms-Universität Bonn; University of Alberta; McGill University Health Centre; Merck KGaA; McGill University","keywords":"Cladribine; Multiple sclerosis; Medicine; Relapsing remitting; Fingolimod; Oncology; Internal medicine; Immunology","authors":[{"name":"Klaus Schmierer","is_ca":false},{"name":"Heinz Wiendl","is_ca":false},{"name":"Frederik Barkhof","is_ca":false},{"name":"Xavier Montalbán","is_ca":false},{"name":"Anat Achiron","is_ca":false},{"name":"Andrew Chan","is_ca":false},{"name":"Suzanne Hodgkinson","is_ca":false},{"name":"Alexandre Prat","is_ca":true},{"name":"Letizia Leocani","is_ca":false},{"name":"Finn Sellebjerg","is_ca":false},{"name":"Patrick Vermersch","is_ca":false},{"name":"Hulin Jin","is_ca":false},{"name":"Laura Sponton","is_ca":false},{"name":"Anita Chudecka","is_ca":false},{"name":"Lidia A. Gardner","is_ca":false},{"name":"Nicola De Stefano","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0542154939765968,"gpt":0.3566189088339214,"spread":0.3024034148573246,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002927394,0.0007167708,0.001168227,0.0002806727,0.0002808269,0.0007036783,0.0003245971,0.0006996258,0.0007855214],"category_scores_gemma":[0.001360701,0.0002137638,0.001123654,0.0002814616,0.0003175076,0.0004275872,0.0003525603,0.0006647118,0.0001668347],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005202767,"about_ca_system_score_gemma":0.0004345333,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000930013,"about_ca_topic_score_gemma":0.001343601,"domain_scores_codex":[0.9994268,0.0002638682,0.00005007903,0.00007670283,0.0001062675,0.00007626192],"domain_scores_gemma":[0.9982731,0.0002960226,0.0006538084,0.0001781332,0.0001637195,0.0004351694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6019501,0.009965834,0.2656805,0.001178044,0.008183772,0.0004706553,0.0005186904,0.002002504,0.01359174,0.0001586659,0.002579865,0.0937196],"study_design_scores_gemma":[0.0459209,0.1056117,0.8377044,0.0001429115,0.004318365,0.0004591289,0.0001386224,0.0009214884,0.002161276,0.0001077056,0.002456965,0.00005647395],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9952296,0.003442164,0.00006556846,0.0000727192,0.00001176677,0.0001064639,0.0005870076,0.000008078216,0.000476692],"genre_scores_gemma":[0.9968179,0.0009371531,0.0001245831,0.0001532799,0.00005615614,0.00009212026,0.001386217,0.000002838486,0.0004295252],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002927394,"threshold_uncertainty_score":0.01548171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3135190823","doi":"10.1177/1756286420987941","title":"Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"AbbVie Biotherapeutics; Biogen","keywords":"Medicine; Daclizumab; Multiple sclerosis; BETA (programming language); Relapsing remitting; Internal medicine; Oncology; Immunology; Monoclonal antibody; Antibody","authors":[{"name":"Ludwig Kappos","is_ca":false},{"name":"Stanley Cohan","is_ca":false},{"name":"Douglas L. Arnold","is_ca":true},{"name":"Randy Robinson","is_ca":false},{"name":"Sami Fam","is_ca":false},{"name":"Becky Parks","is_ca":false},{"name":"Shan Xiao","is_ca":false},{"name":"Wanda Castro-Borrero","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06762489834413932,"gpt":0.341432496039235,"spread":0.2738075976950957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008001976,0.0006539605,0.001466134,0.0002706058,0.0004908653,0.001048807,0.0004846014,0.00123102,0.002827242],"category_scores_gemma":[0.004368751,0.0002983988,0.001339942,0.0002985624,0.0005321603,0.0007965117,0.0005205168,0.001340234,0.0006633578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000502264,"about_ca_system_score_gemma":0.00100574,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002389476,"about_ca_topic_score_gemma":0.0009415008,"domain_scores_codex":[0.9984113,0.0008613209,0.0001686426,0.0001928261,0.0002288083,0.0001371356],"domain_scores_gemma":[0.9957666,0.001145829,0.001426536,0.0004571871,0.0004451158,0.0007586175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8585411,0.01556346,0.0365876,0.001150132,0.00165259,0.0002885624,0.0003464714,0.0007364631,0.01276163,0.0001992166,0.002597317,0.06957552],"study_design_scores_gemma":[0.5042751,0.325843,0.1532616,0.0002956729,0.001624103,0.0004681858,0.0001369809,0.001150737,0.005286284,0.0003137878,0.007270093,0.00007456412],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9910425,0.00260173,0.0004482896,0.0001952551,0.00006818509,0.002459763,0.001563315,0.00006087042,0.00156003],"genre_scores_gemma":[0.9899293,0.0007629991,0.002003819,0.0006309783,0.0001513916,0.002722505,0.002400488,0.00001645705,0.001382069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008001976,"threshold_uncertainty_score":0.04231894,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3173363521","doi":"10.1177/17562864211021177","title":"A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Manitoba","funders":"Biogen","keywords":"Fingolimod; Medicine; Dimethyl fumarate; Propensity score matching; Internal medicine; Hazard ratio; Confidence interval; Multiple sclerosis; Relapsing remitting; Gastroenterology; Disease; Immunology","authors":[{"name":"Amber Salter","is_ca":false},{"name":"Samantha Lancia","is_ca":false},{"name":"Gary Cutter","is_ca":false},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Jason P. Mendoza","is_ca":false},{"name":"James B. Lewin","is_ca":false},{"name":"Robert Fox","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08033330319553018,"gpt":0.335826304475551,"spread":0.2554930012800208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003728244,0.0004664606,0.001116248,0.0006878836,0.0004791786,0.000784028,0.0006621684,0.0009423807,0.002672012],"category_scores_gemma":[0.008424294,0.0004176345,0.002507572,0.0008889921,0.0003686824,0.0005730622,0.0005906316,0.0006936841,0.0003026746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004829445,"about_ca_system_score_gemma":0.0005971261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001816605,"about_ca_topic_score_gemma":0.001129147,"domain_scores_codex":[0.9971074,0.001217539,0.000411223,0.0007291088,0.0002962454,0.0002384156],"domain_scores_gemma":[0.9972017,0.0008110156,0.001090881,0.000456457,0.0002052645,0.000234645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2176619,0.00212573,0.7296032,0.0005762895,0.02004581,0.0004011554,0.0004092954,0.002217085,0.003301556,0.0008772725,0.001351982,0.02142883],"study_design_scores_gemma":[0.01653991,0.03445842,0.9159861,0.0001289806,0.01111496,0.0006792384,0.0005101746,0.01353892,0.001238641,0.00165539,0.004047056,0.0001022022],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972204,0.0007238421,0.000805693,0.00005011594,0.00007220625,0.000159201,0.0005649241,0.000007871546,0.0003956871],"genre_scores_gemma":[0.9987411,0.0001252631,0.0002834072,0.00004532548,0.00002665701,0.000109748,0.0005013333,0.000002608853,0.0001645568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003728244,"threshold_uncertainty_score":0.01971704,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4392157493","doi":"10.1177/17562864231221331","title":"Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"National Health and Medical Research Council; Sanofi Genzyme; Grifols; Všeobecná Fakultní Nemocnice v Praze; Sanofi; European Commission; Canadian Institutes of Health Research; Multiple Sclerosis Australia; Teva Pharmaceutical Industries; Univerzita Karlova v Praze; Medical Research Council; Biogen; Celgene","keywords":"Natalizumab; Medicine; Multiple sclerosis; Disease; Fingolimod; First line therapy; Glatiramer acetate; Clinical significance; Teriflunomide; Intensive care medicine; Oncology; Internal medicine; Immunology","authors":[{"name":"Helmut Butzkueven","is_ca":false},{"name":"Tomáš Kalinčík","is_ca":false},{"name":"Francesco Patti","is_ca":false},{"name":"Mark Slee","is_ca":false},{"name":"Bianca Weinstock‐Guttman","is_ca":false},{"name":"Katherine Buzzard","is_ca":false},{"name":"Olga Skibina","is_ca":false},{"name":"Raed Alroughani","is_ca":false},{"name":"Alexandre Prat","is_ca":true},{"name":"Marc Girard","is_ca":true},{"name":"Dana Horáková","is_ca":false},{"name":"Eva Havrdová","is_ca":false},{"name":"Anneke van der Walt","is_ca":false},{"name":"Sara Eichau","is_ca":false},{"name":"Robert Hyde","is_ca":false},{"name":"Nolan Campbell","is_ca":false},{"name":"Karthik Bodhinathan","is_ca":false},{"name":"Tim Spelman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09250910395706537,"gpt":0.3612026078689723,"spread":0.268693503911907,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008440692,0.0001687045,0.0004643516,0.0003804514,0.0003012355,0.0004822449,0.0002229416,0.0003858621,0.0007091472],"category_scores_gemma":[0.002637924,0.0001936905,0.0006646509,0.0004173257,0.0002060225,0.000363506,0.0002957616,0.0004222709,0.0001130175],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003541406,"about_ca_system_score_gemma":0.0002499819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001454323,"about_ca_topic_score_gemma":0.001264919,"domain_scores_codex":[0.999527,0.0001308723,0.00006805151,0.0001323724,0.00006773438,0.00007405777],"domain_scores_gemma":[0.9986032,0.0002266469,0.0007714292,0.0001044329,0.00006244629,0.0002319175],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007067705,0.0002065802,0.9871209,0.0000245917,0.0004564792,0.0001274678,0.00007294108,0.0002568795,0.0006166917,0.00004228828,0.00008517437,0.003922225],"study_design_scores_gemma":[0.0004562381,0.003237971,0.9940546,0.00001668163,0.0004324542,0.0003593068,0.0001197968,0.00072598,0.0002524882,0.00007030078,0.0002636607,0.00001055385],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9996302,0.0002011553,0.00002593099,0.00001177955,0.000004047166,0.000005557227,0.00005423834,5.922233e-7,0.00006644255],"genre_scores_gemma":[0.9996592,0.00006987248,0.00002916065,0.00001698667,0.000008111385,0.000008115548,0.000164485,3.45273e-7,0.00004377703],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001454323,"threshold_uncertainty_score":0.004463971,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402546531","doi":"10.1177/17562864241273045","title":"The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Hotchkiss Brain Institute; University of Manitoba; Providence Health Care; University of British Columbia; University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Toronto; Women and Children’s Health Research Institute; University of Alberta; Centre for Advancing Health Outcomes; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Multiple Sclerosis Society; Multiple Sclerosis Society of Canada; Michael Smith Health Research BC; Horizon Therapeutics; U.S. Department of Defense; Sanofi; Government of Alberta; Fondation Brain Canada; Teva Pharmaceutical Industries; Biogen; University of Toronto; Biogen Idec; Eli Lilly and Company; Arthritis Society; International Progressive MS Alliance; Roche; University of Calgary","keywords":"Medicine; Multiple sclerosis; Prospective cohort study; Baseline (sea); Cohort; Internal medicine; Oncology; Immunology","authors":[{"name":"Jiwon Oh","is_ca":true},{"name":"Nathalie Arbour","is_ca":true},{"name":"Fabrizio Giuliani","is_ca":true},{"name":"Melanie Guenette","is_ca":true},{"name":"Shannon Kolind","is_ca":true},{"name":"Larry D. Lynd","is_ca":true},{"name":"Ruth Ann Marrie","is_ca":true},{"name":"Luanne M. Metz","is_ca":true},{"name":"Alexandre Prat","is_ca":true},{"name":"Alice Schabas","is_ca":true},{"name":"Penelope Smyth","is_ca":true},{"name":"Roger Tam","is_ca":true},{"name":"Anthony Traboulsee","is_ca":true},{"name":"V. Wee Yong","is_ca":true},{"name":"Scott B. Patten","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05701672225175849,"gpt":0.3518034886168417,"spread":0.2947867663650832,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002083791,0.000497936,0.0006717738,0.001854678,0.003192454,0.001036816,0.001082342,0.0006495979,0.003006926],"category_scores_gemma":[0.00405657,0.0003019457,0.000748117,0.005722137,0.0004571372,0.0004555873,0.0007061888,0.001061443,0.0003537113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009441702,"about_ca_system_score_gemma":0.01989493,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9460704,"about_ca_topic_score_gemma":0.9633375,"domain_scores_codex":[0.9981762,0.000179537,0.0001190682,0.0003092401,0.0008882496,0.0003276428],"domain_scores_gemma":[0.997337,0.0001179981,0.0004052916,0.0001616952,0.00147415,0.0005038037],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003011534,0.00004732893,0.9844406,0.0001187976,0.0002784924,0.0001091314,0.0003041117,0.0001374116,0.0001985929,0.0002809311,0.008281937,0.005501499],"study_design_scores_gemma":[0.00003863927,0.00002765276,0.9960634,0.0000426344,0.00006772482,0.00008167297,0.0001669645,0.00009779273,0.00001824452,0.00004947172,0.003335716,0.00001007703],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8338368,0.006013041,0.001329694,0.001846815,0.00014079,0.001524565,0.1385287,0.00007247594,0.01670711],"genre_scores_gemma":[0.9553885,0.002357421,0.00178111,0.0004300549,0.00004743509,0.0009341965,0.03620359,0.00002451591,0.002833203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05392957,"threshold_uncertainty_score":0.1084943,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411506045","doi":"10.1177/17562864251346326","title":"Therapeutic options for Duchenne muscular dystrophy: hope or hype?","year":2025,"lang":"en","type":"editorial","venue":"Therapeutic Advances in Neurological Disorders","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Muscular dystrophy; Intensive care medicine; Neuroscience; Physical medicine and rehabilitation; Internal medicine; Psychology","authors":[{"name":"Jean K. Mah","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009820308100301598,"gpt":0.3000819553959397,"spread":0.2902616472956381,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007539702,0.003286688,0.003972885,0.002310507,0.002591147,0.006106512,0.003395155,0.01742304,0.01069651],"category_scores_gemma":[0.01993057,0.0009277217,0.002251267,0.00109174,0.002973114,0.005070324,0.001546186,0.02924474,0.007160181],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002950626,"about_ca_system_score_gemma":0.002672169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001824034,"about_ca_topic_score_gemma":0.005549196,"domain_scores_codex":[0.9962035,0.000976954,0.0005273424,0.000347198,0.001669378,0.000275623],"domain_scores_gemma":[0.9836353,0.009211657,0.000747414,0.0003082445,0.003864383,0.002233065],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004293095,0.00001433334,0.0000130701,0.0002804548,0.00002297819,0.0001150656,0.00001142032,0.00003162325,0.00004287098,0.0006102609,0.9909077,0.007907273],"study_design_scores_gemma":[0.00008297985,0.00004511532,0.0001614691,0.0007071506,0.00006336587,0.0003461884,0.00004914256,0.0001750139,0.00005621915,0.002149347,0.9961365,0.00002746548],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.00002447149,0.02389653,0.0001157645,0.04327026,0.9309009,0.00001096691,0.00002291671,0.00003558857,0.001722544],"genre_scores_gemma":[0.0002984727,0.0128238,0.0001113471,0.02813064,0.9530333,0.00001484239,0.00001555615,0.00001811068,0.005553957],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.01742304,"threshold_uncertainty_score":0.03987426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402696194","doi":"10.1177/17562864241276204","title":"Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"International Collaboration On Repair Discoveries; University of British Columbia; McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Ibrutinib; Odds ratio; Ofatumumab; Internal medicine; Epilepsy; Oncology; Adverse Event Reporting System; Population; Discontinuation; Adverse effect; Rituximab; Psychiatry; Leukemia; Lymphoma; Chronic lymphocytic leukemia","authors":[{"name":"Afsaneh Shirani","is_ca":false},{"name":"Nil Saez-Calveras","is_ca":false},{"name":"Jack P. Antel","is_ca":true},{"name":"Moein Yaqubi","is_ca":true},{"name":"Wayne Moore","is_ca":true},{"name":"Amy L. Brewster","is_ca":false},{"name":"Olaf Stüve","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07818901370015804,"gpt":0.3082756776405036,"spread":0.2300866639403456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002316932,0.000174193,0.0003632099,0.001146774,0.0001459004,0.0003964624,0.0002645933,0.0002563687,0.002457584],"category_scores_gemma":[0.006004267,0.00008697308,0.0007827664,0.001652911,0.0001508888,0.000323169,0.0004000495,0.0003867823,0.0001332321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002873525,"about_ca_system_score_gemma":0.0003884301,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001515913,"about_ca_topic_score_gemma":0.001643215,"domain_scores_codex":[0.9978274,0.0007950742,0.0004590093,0.0003449866,0.000399049,0.0001744765],"domain_scores_gemma":[0.9887034,0.003739214,0.006669284,0.0003635153,0.0002768089,0.0002477563],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005169201,0.00001475752,0.9950708,0.00008292888,0.0004592228,0.00003480656,0.00001406374,0.00005728461,0.0001774602,0.00002908757,0.00008615537,0.003456512],"study_design_scores_gemma":[0.00002659612,0.0001942196,0.9978993,0.00002430426,0.0003608453,0.0003323936,0.00002729273,0.0002219494,0.0002341448,0.00005216959,0.0006241261,0.000002683201],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901986,0.005342364,0.0005472123,0.0001871744,0.00001162263,0.00003509201,0.002215752,0.00000853827,0.001453651],"genre_scores_gemma":[0.9985637,0.0004961471,0.0001964055,0.00005039125,0.00001564183,0.00002076814,0.0005447323,0.000001849444,0.0001105014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002457584,"threshold_uncertainty_score":0.01225328,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}